###begin article-title 0
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">S&#8414;</xref>
Arabidopsis GH3.12 (PBS3) Conjugates Amino Acids to 4-Substituted Benzoates and Is Inhibited by Salicylate*Sâƒž
###end article-title 0
###begin p 1
###xml 200 230 200 230 <email xmlns:xlink="http://www.w3.org/1999/xlink">wildermuth@nature.berkeley.edu</email>
 To whom correspondence should be addressed: Dept. of Plant and Microbial Biology, 111 Koshland Hall, University of California, Berkeley, CA 94720-3102. Tel.: 510-643-4861; Fax: 510-642-4995; E-mail: wildermuth@nature.berkeley.edu. 
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 180 200 180 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas syringae</italic>
###xml 265 276 265 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gh3.12/pbs3</italic>
###xml 288 308 288 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana</italic>
###xml 529 537 529 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 567 576 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 619 627 619 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1138 1142 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1327 1328 1327 1328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1326 1328 1326 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1345 1346 1344 1345 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1397 1398 1396 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1398 1401 1397 1400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 1403 1404 1402 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1401 1404 1400 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/K<sub>m</sub></italic>
###xml 1427 1428 1425 1426 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1428 1430 1426 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1434 1436 1432 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1513 1514 1511 1512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1512 1514 1510 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1523 1524 1520 1521 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1526 1527 1523 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1527 1530 1524 1527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 1532 1533 1529 1530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1531 1533 1528 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1545 1546 1541 1542 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1546 1548 1542 1544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1552 1554 1548 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1630 1632 1626 1628 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1641 1642 1636 1637 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 180 200 <span type="species:ncbi:317">Pseudomonas syringae</span>
###xml 288 308 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
Salicylate (SA, 2-hydroxybenzoate) is a phytohormone best known for its role as a critical mediator of local and systemic plant defense responses. In response to pathogens such as Pseudomonas syringae, SA is synthesized and activates widespread gene expression. In gh3.12/pbs3 mutants of Arabidopsis thaliana, induced total SA accumulation is significantly compromised as is SA-dependent gene expression and plant defense. AtGH3 subfamily I and II members have been shown to conjugate phytohormone acyl substrates to amino acids in vitro, with this role supported by in planta analyses. Here we sought to determine the in vitro biochemical activity and kinetic properties of GH3.12/avrPphB susceptible 3 (PBS3), a member of the uncharacterized AtGH3 subfamily III. Using a novel high throughput adenylation assay, we characterized the acyl substrate preference of PBS3. We found PBS3 favors 4-substituted benzoates such as 4-aminobenzoate and 4-hydroxybenzoate, with moderate activity on benzoate and no observed activity with 2-substituted benzoates. Similar to known GH3 enzymes, PBS3 catalyzes the conjugation of specific amino acids (e.g. Glu) to its preferred acyl substrates. Kinetic analyses indicate 4-aminobenzoate and 4-hydroxybenzoate are preferred acyl substrates as PBS3 exhibits both higher affinities (apparent Km = 153 and 459 mum, respectively) and higher catalytic efficiencies (kcat/Km = 0.0179 and 0.0444 mum-1 min-1, respectively) with these acyl substrates compared with benzoate (apparent Km = 867 mum, kcat/Km = 0.0046 mum-1 min-1). Notably, SA specifically and reversibly inhibits PBS3 activity with an IC50 of 15 mum. This suggests a general mechanism for the rapid, reversible regulation of GH3 activity and small molecule cross-talk. For PBS3, this may allow for coordination of flux through diverse chorismate-derived pathways.
###end p 4
###begin p 5
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 5
###begin p 6
###xml 27 71 27 71 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Science Foundation Arabidopsis 2010</grant-sponsor>
###xml 78 89 78 89 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">MCB-0420267</grant-num>
This work was supported by National Science Foundation Arabidopsis 2010 Grant MCB-0420267 (to M. C. W.).
###end p 6
###begin p 7
The on-line version of this article (available at ) contains supplemental Methods S1 and Figs. S1 and S2.
###end p 7
###begin p 8
###xml 18 29 18 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 330 350 330 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas syringae</italic>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tomato</italic>
###xml 392 400 392 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">avrPphB,</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPS5</italic>
###xml 474 485 474 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 601 612 601 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 632 643 632 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 648 658 648 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maculicola</italic>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PBS3</italic>
###xml 743 744 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 764 765 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 796 807 796 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 823 829 823 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 849 855 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-2</italic>
###xml 978 981 978 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PR1</italic>
###xml 1031 1032 1031 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 1051 1057 1051 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 1094 1095 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">2</xref>
###xml 1174 1175 1174 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 330 361 <span type="species:ncbi:323">Pseudomonas syringae pv. tomato</span>
###xml 601 612 <span type="species:ncbi:317">P. syringae</span>
###xml 632 658 <span type="species:ncbi:59511">P. syringae pv. maculicola</span>
###xml 796 807 <span type="species:ncbi:317">P. syringae</span>
Mutant screens in Arabidopsis have successfully identified many components of plant disease resistance pathways, with a number of these mutants exhibiting altered phytohormone synthesis, perception, or signaling (1). The pbs3-1 ethyl methanesulfonate mutant was first isolated in a screen for enhanced susceptibility to avirulent Pseudomonas syringae pv. tomato DC3000, carrying the effector avrPphB, resistance to which is mediated by the plant resistance (R) gene RPS5 in Arabidopsis (2). Our subsequent analysis with Roger Innes revealed that the pbs3-1 mutant is also more susceptible to virulent P. syringae strains, including P. syringae pv. maculicola ES4326, suggesting a more general role for PBS3 than in directly mediating effector-R gene interactions (3). Furthermore, in response to P. syringae pathovars, the pbs3-1 EMS mutant and the pbs3-2 T-DNA insertion line exhibited reduced total SA accumulation and expression of the SA-dependent pathogenesis-related gene PR1 (At2g14610) in comparison with wild type plants (3). The mutation in pbs3-1 was then mapped and cloned, and PBS32 was found to be AtGH3.12 (At5g13320), a member of the AtGH3 multigene family (3).
###end p 8
###begin p 9
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 108 119 108 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Glycine max</italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 709 715 709 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 108 119 <span type="species:ncbi:3847">Glycine max</span>
The first GH3 gene was characterized by Guilfoyle and co-workers (4) as an early auxin-responsive gene from Glycine max. Homologs have since been identified in many other plant species and in bacteria (5). The GH3 family is part of the broader acyl-adenylate/thioester-forming enzyme family, also called the firefly luciferase family (6). This superfamily consists of enzymes that catalyze a variety of reactions with a common first step as follows: the transfer of AMP from ATP to the carboxylic acid group of an acyl substrate, forming an activated acyl-adenylate intermediate. GH3 enzymes are unique within this superfamily in that amino acid conjugation occurs in the absence of a thioester intermediate. Fig. 1 shows the reaction catalyzed by GH3 enzymes, with benzoate as the acyl substrate. To date, biochemical activity has only been demonstrated for select plant GH3 enzymes (discussed below). Furthermore, mechanistic analyses are hampered by the lack of sequence conservation between GH3 and other acyl-adenylase/thioester-forming superfamily members and no structural information for any GH3 family member.
###end p 9
###begin p 10
###xml 47 58 47 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 942 946 942 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TIR1</sup>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1288 1289 1288 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">3</xref>
###xml 1468 1469 1468 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
The known acyl substrate specificity of the 19 Arabidopsis AtGH3 proteins corresponds to their phylogenetic relationship (6) that divides the family into three groups (supplemental Fig. S1). Group I includes JAR1, which catalyzes the formation of JA-Ile, an active form of the phytohormone jasmonate (JA) (7). JA-Ile promotes the interaction of the F-box protein COI1 with JAZ JA repressor family members (8). This interaction results in degradation of the JAZ repressor by the ubiquitin ligase-dependent 26 S proteasome followed by the activation of the associated JA-dependent responses (9-11). Group II is composed of several proteins that catalyze the formation of auxin-amino acid conjugates (12). Conjugation of indole-3-acetate (IAA) with Asp and Glu targets the phytohormone IAA for catabolism, whereas Ala and Leu conjugates of IAA appear to be inactive storage forms of IAA (13). IAA directly binds to TIR1, the F-box subunit of SCFTIR1, enabling its interaction with the Aux/IAA family of auxin transcriptional repressors, degradation of the repressor, and activation of IAA-associated responses (14, 15). In contrast, IAA-amino acid conjugates are too bulky to fit into the auxin binding pocket of TIR1 and do not promote complex formation between TIR1 and Aux/IAA repressors.3 Group III, which includes PBS3 (AtGH3.12), contains proteins for which the substrate specificity has not yet been reported, as these proteins were inactive on tested substrates (6).
###end p 10
###begin p 11
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 345 356 345 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 361 371 361 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">savastanoi</italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 455 466 455 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 471 477 471 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tomato</italic>
###xml 489 500 489 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 505 515 505 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maculicola</italic>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 698 709 698 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 714 724 714 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maculicola</italic>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 345 371 <span type="species:ncbi:29438">P. syringae pv. savastanoi</span>
###xml 455 477 <span type="species:ncbi:323">P. syringae pv. tomato</span>
###xml 489 515 <span type="species:ncbi:59511">P. syringae pv. maculicola</span>
###xml 698 724 <span type="species:ncbi:59511">P. syringae pv. maculicola</span>
The amino acid conjugation reaction catalyzed by characterized GH3 enzymes plays a critical role in plant hormone homeostasis and plant-microbe interactions (7, 13). Not only do plants regulate active phytohormone forms through amino acid conjugation, but some plant pathogens also manipulate phytohormone conjugation and response. For example, P. syringae pv. savastanoi encodes an IAA-AA synthetase that is required for full virulence on oleander (16). P. syringae pv. tomato DC3000 and P. syringae pv. maculicola ES4326 synthesize the phytotoxin coronatine, an analog of JA-Ile, that activates JA-Ile-dependent responses and is required for full virulence (17). Notably, the HopW1-1 effector of P. syringae pv. maculicola ES4326 targets PBS3, altering host SA signal transduction pathways (18).
###end p 11
###begin p 12
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3</italic>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 639 645 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
Because PBS3 is a GH3 protein and pbs3 mutants exhibit SA-deficient phenotypes, we proposed that PBS3 acts upstream of SA, on SA, or on a compound that could compete with SA (3). In the last case, such a compound might bind to a metabolic or regulatory enzyme that normally binds SA (3). Here we systematically examine the acyl substrate and amino acid preference of PBS3 followed by determination of the kinetic and catalytic properties of PBS3. In addition, for the first time for any GH3 member, we assess the influence of putative inhibitors on enzymatic activity. The impact of each of the two point mutations in the lack of function pbs3-1 EMS mutant (3) is also ascertained. Together, these findings provide a framework to explore the role of PBS3 in pathogen-induced SA accumulation and disease resistance. Furthermore, they support an underexplored and significant role for 4-substituted benzoates in plant-pathogen interactions.
###end p 12
###begin title 13
EXPERIMENTAL PROCEDURES
###end title 13
###begin p 14
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Materials and General Protocols</italic>
###xml 233 236 233 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">254</sub>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
Materials and General Protocols-All specialty reagents and chemicals were purchased from Sigma unless otherwise specified. HPLC-grade solvents (EMD Biosciences) were employed in the HPLC analyses. TLC plates were silica gel 60 with F254 from EMD Biosciences. Commonly utilized protein and molecular biology reagents and protocols were prepared and used as described in Ref. 19.
###end p 14
###begin p 15
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AtPBS3 Cloning and Purification</italic>
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AtPBS3</italic>
###xml 97 117 97 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis thaliana</italic>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AtPBS3.</italic>
###xml 484 500 484 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 736 737 722 723 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 760 761 743 744 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 1628 1629 1592 1593 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1661 1662 1625 1626 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 97 117 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 484 500 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1516 1522 <span type="species:ncbi:9913">bovine</span>
AtPBS3 Cloning and Purification-The AtPBS3 coding sequence was amplified from cDNA isolated from Arabidopsis thaliana ecotype Col-0 and inserted into a pET-28a vector (Novagen) as an NdeI/BamHI fragment using forward primer 5'tcatgacatatgaagccaatcttcgata and reverse primer 5'cacgtggtgggatcctcaaatactgaagaatt. The resulting construct, pET-His-PBS3, contains an N-terminal histidine tag fused to the coding region of AtPBS3. Crude cell extracts were prepared from a 2-liter culture of Escherichia coli Rosetta2 (DE3) cells transformed with pET-His-PBS3 grown in TB media containing 0.2% glucose, 50 mug/ml kanamycin, and 30 mug/ml chloramphenicol. Cultures were grown at 37 degreesC to mid-log phase and shifted to 18 degreesC, and 0.1 mm isopropyl 1-thio-beta-d-galactopyranoside was added to induce His-PBS3 synthesis. Cells were harvested after shaking overnight (approximately25 g wet weight) and stored at -20 degreesC. His-PBS3 was then purified using nickel-nitrilotriacetic acid His-Bind resin (Novagen) according to manufacturer's directions. His-PBS3 was the only visible protein when 10 mug of this eluant was resolved by SDS-PAGE and visualized using Coomassie Blue. Thrombin (Novagen) was used to cleave the histidine tag. As His-PBS3 and thrombin-cleaved PBS3 displayed similar activity on a set of five acyl substrates, His-PBS3 was utilized unless specified. Protein concentrations were determined by a Bradford assay modified for 96-well plate format using Coomassie Blue G-250 (EM Biosciences) with bovine serum albumin as the standard. Aliquots of the purified recombinant PBS3 proteins (5.3-9.5 mg/ml in 100 mm Tris, pH 7.7, 10% glycerol, 1 mm DTT) were stored at -80 degreesC. The same batch of enzyme was used for each set of assays reported in a single figure or table, with assays repeated with enzyme from at least one other batch to confirm results. In all assays, the appropriate enzyme concentrations were utilized such that velocity was linear with increasing enzyme concentration.
###end p 15
###begin p 16
###xml 0 43 0 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Generation and Purification of PBS3 Mutants</italic>
Generation and Purification of PBS3 Mutants-Amino acid substitutions were introduced into the pET-His-PBS3 plasmid using the QuikChange II site-directed mutagenesis kit (Stratagene) with forward primer 5'ccacgtgttgtttggtaatgaaggagtcgcttgataatgtttac and reverse primer 5'gtaaacattatcaagcgactccttcattaccaaacaacacgtgg to make the E502R mutation and forward primer 5'gatgtcgattcaaagacggatcgaccgggcctctcgagataagagtggtg and reverse primer 5'caccactcttatctcgagaggcccggtcgatccgtctttgaatcgacatc to make the I519T mutation. The double mutant was made using the pET-His-I519K plasmid with the E502R forward and reverse primers. The His-tagged single and double mutant proteins were purified as described for wild type PBS3, above.
###end p 16
###begin p 17
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Adenylation Reaction</italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 478 479 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 604 605 601 602 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 644 645 641 642 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 650 651 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 658 659 655 656 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 668 669 665 666 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 683 684 680 681 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 891 892 886 887 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 906 907 901 902 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 974 975 969 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 999 1001 994 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1019 1020 1014 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 1031 1032 1026 1027 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1037 1038 1032 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1647 1648 1635 1636 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1690 1691 1677 1678 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1691 1693 1678 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1696 1698 1683 1685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1887 1889 1874 1876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
Adenylation Reaction-His-PBS3 adenylation activity was monitored spectrophotometrically at 340 nm by coupling the production of pyrophosphate to oxidation of NADH using pyrophosphate reagent (Sigma) (20). The reagent contained the coupling enzymes fructose-6-phosphate kinase, aldolase, triose-phosphate isomerase, glycerophosphate dehydrogenase, and appropriate substrates and cofactors, including NADH. The pyrophosphate reagent was reconstituted in 4 ml of double distilled H2O and used at a volume of 65 mul per 200-mul reaction. For the screen of substrates, reaction mixtures (200 mul) were in 45 mm imidazole, pH 7.4, and contained 5.0 mm MgCl2, 2.5 mm ATP, 1 mm DTT, 0.1-10 mm substrate, and 100 mug of His-PBS3 enzyme in addition to the pyrophosphate reagent. For determination of kinetic parameters for ATP, reactions contained 50 mug/ml His-PBS3 enzyme, pyrophosphate reagent, 1 mm DTT, and 10 mm acyl substrate. The concentration of ATP was varied while either (a) maintaining a 1.5:1 Mg2+ to ATP ratio or (b) with 10 mm MgCl2. Three replicates were performed for each substrate or concentration value. The reactions were initiated with the addition of substrate to a 96-well plate preheated to 30 degreesC and analyzed using a Spectromax Plus microplate spectrophotometer (Molecular Devices). The change in absorbance at 340 nm was measured every 10-15 s for at least 20 min and converted to velocity by least squares fitting of each curve using the accompanying program SOFTmax PRO 3.0 with manual assessment/confirmation of the linear range. The velocity of a no His-PBS3 control was subtracted; this velocity was on average 0.16 mum/min. An extinction coefficient of 6.22 mum-1 cm-1 for NADH was used to convert velocity values from milli-absorbance units/min to micromolar/min. Kinetic parameters were estimated by fitting initial velocity values to the Hanes equation (21).
###end p 17
###begin p 18
###xml 0 47 0 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amino Acid Conjugation Reaction (Full Reaction)</italic>
###xml 88 89 87 88 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 127 128 126 127 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 133 134 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 141 142 140 141 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 153 154 152 153 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 165 166 164 165 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 188 189 187 188 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 379 382 371 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">254</sub>
###xml 853 858 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 1075 1076 1067 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1074 1076 1066 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1215 1218 1207 1210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">305</sub>
###xml 1221 1227 1213 1219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">407 nm</sub>
Amino Acid Conjugation Reaction (Full Reaction)-Reaction mixtures (200 mul) were in 50 mm Tris-HCl, pH 8.5, and contained 5.0 mm MgCl2, 2.5 mm ATP, 1.0 mm DTT, 1.0 mm acyl substrate, 1.0 mm amino acid, and 100 mug/ml His-PBS3 enzyme. Reactions were incubated at 30 degreesC for 2 h and monitored by TLC and/or HPLC. Reaction mixtures and standards were spotted on silica gel 60 F254 plates (EMD Biosciences) and developed in either 30:60:10 dichloromethane/ethyl acetate/formic acid or 8:1:1 isopropyl alcohol/ammonium hydroxide/water (for basic and hydrophilic amino acids). The method used to detect the conjugates varied by substrate. pABA conjugates were detected by staining TLC plates with vanillin reagent (6% (w/v) vanillic acid and 1% sulfuric acid in ethanol) and by visualizing TLC plates under short wavelength UV. 4-HBA, vanillic acid, and trans-cinnamic acid conjugates were detected by visualizing TLC plates under short wavelength UV light. BA conjugates were detected by HPLC using a UV detector at 233 nm. HPLC conditions are the same as those used in the Km determination (see below). SA was analyzed by TLC visualized under short wavelength UV light and by HPLC using a fluorescence detector (ex305/em407 nm); however, no spots or peaks associated with SA-conjugates were detected.
###end p 18
###begin p 19
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub> Determinations</italic>
###xml 58 59 57 58 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 97 98 96 97 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 103 104 102 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 111 112 110 111 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 121 122 120 121 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 132 133 131 132 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 336 337 332 333 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 344 345 340 341 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 870 871 863 864 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1122 1123 1115 1116 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1349 1350 1342 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1359 1360 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1387 1388 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1397 1398 1390 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1406 1407 1399 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1432 1433 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1586 1589 1579 1582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">290</sub>
###xml 1592 1598 1585 1591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340 nm</sub>
###xml 1669 1670 1662 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1679 1680 1672 1673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1696 1697 1689 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1706 1707 1699 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1715 1716 1708 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1743 1744 1736 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1871 1872 1864 1865 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2033 2034 2026 2027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 2043 2044 2036 2037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 2127 2128 2120 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 2137 2138 2130 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 2145 2146 2138 2139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 2179 2180 2172 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
Km Determinations-Reaction mixtures (200 mul) were in 50 mm Tris-HCl, pH 8.5, and contained 5.0 mm MgCl2, 5.0 mm ATP, 1 mm DTT, 10 mm glutamate, varying concentrations of 4-HBA, pABA, or BA, and 50 mug/ml His-PBS3 (reaction with 4-HBA) or 125 mug/ml His-PBS3 (reactions with pABA and BA). Acyl substrate concentrations ranged from 50 mum to 5 mm. Reactions were quenched every 2 min by diluting the reaction mixture 10-fold into 2.5% HCl. Samples were filtered through a 0.2-mum Millex-LG syringe filter (Millipore), and a 50-mul aliquot was injected into a Shimadzu SCL-10AVP series HPLC system equipped with a Shimadzu SPD-10AVP photodiode array detector and a Shimadzu RF-10AXL fluorescence detector. A 5-mum, 15 cm x 4.6-mm inner diameter Supelcosil LC-ABZPlus column (Supelco) preceded by a LC-ABZ-Plus guard column was pre-equilibrated in 5% acetonitrile with 25 mm potassium phosphate buffer (initial HPLC buffer), pH 2.5, at a flow rate of 1.0 ml/min. The elution program and detection method varied by substrate. For BA, the initial HPLC buffer was run for 10 min and then changed to 52% acetonitrile and 48% 25 mm potassium phosphate buffer over 12 min. Under these conditions, BA-Glu eluted at 15.5 min and BA at 19 min. Elution was monitored by UV absorbance at 233 nm. Authentic samples were used to generate calibration curves for BA (y = 0.0397x) and BA-Glu (TCI America; y = 0.0407x), with x in absorbance units and y in nanomolar compound. For pABA, pABA eluted at 7.5 min and pABA-Glu eluted at 5.0 min using the BA program. Elution was monitored by fluorescence at ex290/em340 nm. Authentic samples were used to generate calibration curves for pABA (y = 0.2585x) and pABA-Glu (y = 0.1045x), with x in fluorescence units and y in nanomolar compound). For 4-HBA, the initial HPLC buffer was run for 4 min and then changed to 52% acetonitrile and 48% 25 mm potassium phosphate buffer over 7 min. Elution was monitored by UV absorbance at 254 nm. An authentic sample of 4-HBA was used to generate a calibration curve (y = 0.0274x), and synthesized 4-HBA-Glu (see below) was used to generate a calibration curve (y = 0.0318x) with x in UV absorbance area units and y in nanomolar compound. Under these conditions, 4-HBA eluted at 9.7 min and 4-HBA-Glu eluted at 8.3 min. The reaction velocity with each substrate concentration was determined from a linear fit of four time points. Kinetic parameters were estimated by fitting initial velocity values to the Hanes equation as above, with data from at least six substrate concentrations. Nonlinear curve fitting using Synergy KaleidaGraph version 4.0 gave very similar results.
###end p 19
###begin p 20
###xml 0 47 0 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mass Spectrometry to Verify 4-HBA-Glu Formation</italic>
###xml 208 209 207 208 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 609 610 608 609 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1262 1263 1261 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1264 1265 1263 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
Mass Spectrometry to Verify 4-HBA-Glu Formation-A 5-mum, 15-cm x 4.6-mm inner diameter Prevail C18 column (Alltech) preceded by a 7.5-cm x 4.6-mm guard column was pre-equilibrated in 5% acetonitrile with 25 mm formate buffer, pH 2.8 (initial HPLC buffer), at a flow rate of 1.0 ml/min. The initial buffer was run for 7 min and then changed to 52% acetonitrile over 15 min. The putative 4-HBA-Glu peak eluting at 11.3-11.9 min was collected and dried down under vacuum. This sample was rerun using our standard HPLC assay for verification. Samples for LC-MS analysis were resuspended in a 50:50 mixture of 25 mm ammonium formate and acetonitrile and analyzed using a Thermo Fisher Surveyor HPLC with a Phenomenex C18 2 x 150-mm column and a Thermo Fisher LCQ classic mass spectrometer at the Vincent Coates Foundation Mass Spectrometry Laboratory (Stanford University). LC-MS with electrospray ionization-positive ion analysis employed a C18 column with similar elution scheme. MS-MS fragmentation was performed on the putative dominant ion peak for further confirmation of compound identity. The sample was also analyzed by nanospray infusion on the Q-TOF mass spectrometer (Waters Micromass Q-TOF hybrid quadrupole time of flight) with MS-MS performed on 268.1 m/z.
###end p 20
###begin p 21
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Synthesis of 4-HBA-Glu Standard</italic>
###xml 217 218 217 218 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 262 263 262 263 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 433 435 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">13</sup>
Synthesis of 4-HBA-Glu Standard-As 4-HBA-Glu is not commercially available, it was synthesized for calibration of the HPLC. Briefly, 4-acetoxybenzoic acid was converted to the acyl chloride and condensed with diethyl l-glutamate to form diethyl 4-acetoxybenzoyl-l-glutamate. The protecting groups were removed in base to yield 4-HBA-Glu as a white crystalline solid with 99% purity by HPLC. The structure was confirmed by 1H NMR and 13C NMR. See supplemental Method S1 for complete procedures and spectral data.
###end p 21
###begin p 22
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition Studies</italic>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 235 236 234 235 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 279 280 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 278 280 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 288 289 286 287 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 481 482 478 479 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 521 522 518 519 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 527 528 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 535 536 532 533 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 545 546 542 543 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 558 559 554 555 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 671 672 665 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 773 774 766 767 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 926 927 919 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1070 1071 1062 1063 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Inhibition Studies-Inhibition of PBS3 amino acid conjugation was assessed with SA using our HPLC assay to monitor pABA-Glu formation. Reaction conditions were the same as for the Km experiment (above), with the addition of SA (5-600 mum). A pABA concentration equivalent to the Km (150 mum) was used. The adenylation assay was then used to measure the effect of potential inhibitors on adenylation velocity using pABA as the acyl substrate. Reaction mixtures (200 mul) were in 45 mm imidazole, pH 7.4, and contained 5.0 mm MgCl2, 5.0 mm ATP, 1 mm DTT, 150 mum pABA, 100 mug/ml His-PBS3 enzyme, 65 mul of pyrophosphate reagent reconstituted in 4.0 ml of double distilled H2O, and potential inhibitors. SA and MeSA were tested over a range of concentrations from 10 to 600 mum. We verified that the decreased velocity with SA was due to inhibition of PBS3 rather than of the coupled reactions by testing the effect of SA with PPi as a substrate; we observed no change in activity. Other potential inhibitors (INA, 2,4-DHBA, 3-HBA, IAA, and JA) were tested at 30 and 300 mum only.
###end p 22
###begin p 23
###xml 0 54 0 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Potential Inhibition of ICS1-catalyzed SA Biosynthesis</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 600 601 598 599 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 613 614 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 612 614 610 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 647 648 645 646 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 668 669 665 666 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 739 740 734 735 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 782 783 777 778 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 788 789 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 868 869 862 863 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 978 979 972 973 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1020 1021 1014 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Potential Inhibition of ICS1-catalyzed SA Biosynthesis-To evaluate compounds as inhibitors of the AtICS1-catalyzed conversion of chorismate to isochorismate, a coupled spectrophotometric assay was used (22). The conversion of chorismate to isochorismate was coupled to the oxidation of NADH through the coupling enzymes isochorismate pyruvate lyase (recombinant PchB), which converts isochorismate to pyruvate and SA, and lactic dehydrogenase (Sigma L1254), which converts pyruvate to lactate in an NADH-dependent fashion. The 200-mul reaction contained an effective chorismate concentration of 90 mum (apparent Km of AtICS1 for chorismate), 0.4 mm NADH, 0.833 mug/ml l-lactic dehydrogenase, 32.0 mug/ml PchB, and 10 mug/ml AtICS1 in 100 mm Tris, pH 7.7, with 10% glycerol, and 10 mm MgCl2. We assessed AtICS1 activity in duplicate for reactions with or without 200 mum 4-HBA, pABA, or pABA-Glu and for the appropriate no enzyme controls. We also performed these assays with 1 mm 4-HBA, pABA, or pABA-Glu. The Student's t test (alpha = 0.1) was used to evaluate whether any observed small changes in activity were statistically significant.
###end p 23
###begin p 24
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Potential Inhibition of Isochorismate Pyruvate Lyase</italic>
###xml 349 350 347 348 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 383 384 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 382 384 380 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 480 481 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 479 481 477 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 495 508 493 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa</italic>
###xml 542 543 539 540 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 545 547 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 624 625 620 621 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 709 710 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 881 883 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 495 508 <span type="species:ncbi:444978|species:ncbi:287">P. aeruginosa</span>
Potential Inhibition of Isochorismate Pyruvate Lyase-To evaluate compounds as inhibitors of the isochorismate pyruvate lyase (IPL) reaction in which isochorismate is converted to SA, we employed a modified version of our coupled ICS spectrophotometric assay, described above. In this case, 50 mug/reaction of recombinant PchB was employed with 60 mum isochorismate, the approximate Km of our recombinant enzyme for isochorismate under our assay conditions. The reported apparent Km for purified P. aeruginosa PchB for isochorismate is 12.5 mum (23). We assessed IPL activity in duplicate for reactions with or without 100 mum 4-HBA, pABA, or pABA-Glu and for the appropriate no enzyme controls. The Student's t test (alpha = 0.1) was used to evaluate whether any observed small changes in activity were statistically significant. Isochorismate was prepared and purified as in Ref. 22.
###end p 24
###begin p 25
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate.</bold>
###xml 9 174 9 174 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26"><bold>Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate.</bold> Adenylation of the acyl substrate is followed by formation of the amino acid conjugate.</p>
###xml 9 174 9 174 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26"><bold>Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate.</bold> Adenylation of the acyl substrate is followed by formation of the amino acid conjugate.</p></caption>
###xml 174 174 174 174 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0180971650001"/>
###xml 0 174 0 174 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="26"><bold>Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate.</bold> Adenylation of the acyl substrate is followed by formation of the amino acid conjugate.</p></caption><graphic xlink:href="zbc0180971650001"/></fig>
FIGURE 1.Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate. Adenylation of the acyl substrate is followed by formation of the amino acid conjugate.
###end p 25
###begin p 26
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate.</bold>
Reaction catalyzed by GH3 enzymes, shown with benzoate as the acyl substrate. Adenylation of the acyl substrate is followed by formation of the amino acid conjugate.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin p 28
###xml 0 40 0 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Determination of Acyl Substrates of PBS3</italic>
###xml 418 424 418 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 697 698 697 698 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 822 823 821 822 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 835 836 834 835 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1107 1108 1106 1107 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Determination of Acyl Substrates of PBS3-To explore the biochemical activity of PBS3, we overexpressed and purified recombinant His-tagged PBS3. We also developed a novel high throughput, 96-well format adenylation assay for use in determining putative acyl substrate(s) of PBS3. In this assay, the release of pyrophosphate, which occurs when the acyl substrate is adenylated to form the acyl substrate-AMP conjugate (Fig. 1), is coupled to the oxidation of NADH that can be measured spectrophotometrically (20). This allows for rapid kinetic assessment of the GH3 adenylation reaction that is not readily performed using standard radiolabeled PPi exchange assays. We report our findings using 1 mm acyl substrate to allow for comparison with previously reported GH3 acyl substrate surveys (6, 12). Assessments with 100 mum and/or 10 mm substrate were performed for substrates with moderate and low activity to ensure we had not missed the linear range of activity. We did not observed significant differences in the relative activities of PBS3 with these acyl substrates compared with our results using 1 mm substrate.
###end p 28
###begin p 29
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PR1</italic>
###xml 68 79 68 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3</italic>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 698 705 698 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1044 1049 1044 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 68 79 <span type="species:ncbi:317">P. syringae</span>
The reduced accumulation of SA and expression of PR1 in response to P. syringae in pbs3 mutants suggested PBS3 might act upstream of SA, on SA, or on a compound that could compete with SA in binding (either as a substrate or modulator of activity) to an SA-binding metabolic or regulatory enzyme (3). Therefore, our initial screen consisted of three overlapping classes of commercially available compounds as follows: 1) phytohormones, including SA and the SA functional analog INA; 2) compounds that are structurally similar to SA (i.e. benzoates); and 3) compounds in the chorismate pathway. We found that recombinant PBS3 did not exhibit significant activity on any of the phytohormones tested (Table 1), including SA and the functional SA analog 2,6-dichloroisonicotinic acid (INA). In contrast, recombinant PBS3 was very active on BA and 4-HBA; respective activities were 59.6 and 135.2 nmol/min/mg for BA and 4-HBA. Moderate activity was observed for the chorismate pathway compounds chorismate (32.9 nmol/min/mg), a precursor of SA, and trans-cinnamate (21.3 nmol/min/mg).
###end p 29
###begin p 30
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 7 36 7 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Initial acyl substrate screen</bold>
###xml 7 36 7 36 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31"><bold>Initial acyl substrate screen</bold></p>
###xml 7 36 7 36 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31"><bold>Initial acyl substrate screen</bold></p></caption>
###xml 36 36 36 36 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 36 44 36 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activity</bold>
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup><italic>a</italic></sup></bold>
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref>
###xml 36 45 36 45 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Activity</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></th>
###xml 36 45 36 45 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>Activity</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></th></tr>
###xml 36 45 36 45 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>Activity</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></th></tr></thead>
###xml 45 45 45 45 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 45 56 45 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nmol/min/mg</italic>
###xml 45 56 45 56 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>nmol/min/mg</italic></td>
###xml 45 56 45 56 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol/min/mg</italic></td></tr>
###xml 56 69 56 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phytohormones</bold>
###xml 56 69 56 69 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>Phytohormones</bold></td>
###xml 69 69 69 69 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 56 69 56 69 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><bold>Phytohormones</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 69 91 69 91 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Indole-3-acetate </td>
###xml 91 104 91 102 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.5 &#177; 0.1 </td>
###xml 69 104 69 102 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Indole-3-acetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.5 &#177; 0.1 </td></tr>
###xml 104 119 102 117 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Jasmonate </td>
###xml 119 132 117 128 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.9 &#177; 0.1 </td>
###xml 104 132 102 128 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Jasmonate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.9 &#177; 0.1 </td></tr>
###xml 132 150 128 146 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Gibberellate </td>
###xml 150 163 146 157 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.1 </td>
###xml 132 163 128 157 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Gibberellate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.1 </td></tr>
###xml 163 178 157 172 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Abscisate </td>
###xml 178 191 172 183 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.8 &#177; 0.1 </td>
###xml 163 191 157 183 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Abscisate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.8 &#177; 0.1 </td></tr>
###xml 191 207 183 199 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate </td>
###xml 207 220 199 210 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td>
###xml 191 220 183 210 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr>
###xml 220 229 210 219 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;INA </td>
###xml 229 242 219 230 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.2 </td>
###xml 220 242 210 230 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.2 </td></tr>
###xml 45 242 45 230 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol/min/mg</italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Phytohormones</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Indole-3-acetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.5 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Jasmonate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.9 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Gibberellate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Abscisate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.8 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.2 </td></tr></tbody>
###xml 242 251 230 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Benzoates</bold>
###xml 242 251 230 239 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>Benzoates</bold></td>
###xml 251 251 239 239 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 242 251 230 239 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><bold>Benzoates</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 251 265 239 253 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Benzoate </td>
###xml 265 279 253 265 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 59.6 &#177; 1.1 </td>
###xml 251 279 239 265 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Benzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 59.6 &#177; 1.1 </td></tr>
###xml 279 298 265 284 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylacetate </td>
###xml 298 311 284 295 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.3 &#177; 0.1 </td>
###xml 279 311 265 295 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylacetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.3 &#177; 0.1 </td></tr>
###xml 311 347 295 331 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate (2-hydroxybenzoate) </td>
###xml 347 360 331 342 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td>
###xml 311 360 295 342 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate (2-hydroxybenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr>
###xml 360 383 342 365 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;4-Hydroxybenzoate </td>
###xml 383 398 365 378 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 135.2 &#177; 8.6 </td>
###xml 360 398 342 378 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;4-Hydroxybenzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 135.2 &#177; 8.6 </td></tr>
###xml 242 398 230 378 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Benzoates</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Benzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 59.6 &#177; 1.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylacetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.3 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate (2-hydroxybenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;4-Hydroxybenzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 135.2 &#177; 8.6 </td></tr></tbody>
###xml 398 426 378 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chorismate pathway compounds</bold>
###xml 398 426 378 406 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><bold>Chorismate pathway compounds</bold></td>
###xml 426 426 406 406 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 398 426 378 406 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><bold>Chorismate pathway compounds</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 441 442 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 441 442 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref>
###xml 426 442 406 422 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Chorismate<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td>
###xml 442 456 422 434 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 32.9 &#177; 2.0 </td>
###xml 426 456 406 434 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Chorismate<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 32.9 &#177; 2.0 </td></tr>
###xml 456 472 434 450 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Prephenate </td>
###xml 472 486 450 462 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 10.1 &#177; 0.4 </td>
###xml 456 486 434 462 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Prephenate </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.1 &#177; 0.4 </td></tr>
###xml 486 522 462 498 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Anthranilate (2-aminobenzoate) </td>
###xml 522 535 498 509 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.7 &#177; 1.1 </td>
###xml 486 535 462 509 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Anthranilate (2-aminobenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.7 &#177; 1.1 </td></tr>
###xml 535 554 509 528 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylalanine </td>
###xml 554 567 528 539 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td>
###xml 535 567 509 539 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylalanine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr>
###xml 567 581 539 553 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tyrosine </td>
###xml 581 594 553 564 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td>
###xml 567 594 539 564 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tyrosine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr>
###xml 594 610 564 580 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tryptophan </td>
###xml 610 623 580 591 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td>
###xml 594 623 564 591 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tryptophan </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr>
###xml 628 633 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 623 644 591 612 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;<italic>trans</italic>-Cinnamate </td>
###xml 644 658 612 624 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 21.3 &#177; 1.8 </td>
###xml 623 658 591 624 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;<italic>trans</italic>-Cinnamate </td><td colspan="1" rowspan="1" align="center" valign="top"> 21.3 &#177; 1.8 </td></tr>
###xml 398 658 378 624 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Chorismate pathway compounds</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Chorismate<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 32.9 &#177; 2.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Prephenate </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.1 &#177; 0.4 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Anthranilate (2-aminobenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.7 &#177; 1.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylalanine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tyrosine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tryptophan </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;<italic>trans</italic>-Cinnamate </td><td colspan="1" rowspan="1" align="center" valign="top"> 21.3 &#177; 1.8 </td></tr></tbody>
###xml 36 658 36 624 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>Activity</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol/min/mg</italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Phytohormones</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Indole-3-acetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.5 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Jasmonate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.9 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Gibberellate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Abscisate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.8 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.2 </td></tr></tbody><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Benzoates</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Benzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 59.6 &#177; 1.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylacetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.3 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate (2-hydroxybenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;4-Hydroxybenzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 135.2 &#177; 8.6 </td></tr></tbody><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Chorismate pathway compounds</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Chorismate<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 32.9 &#177; 2.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Prephenate </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.1 &#177; 0.4 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Anthranilate (2-aminobenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.7 &#177; 1.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylalanine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tyrosine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tryptophan </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;<italic>trans</italic>-Cinnamate </td><td colspan="1" rowspan="1" align="center" valign="top"> 21.3 &#177; 1.8 </td></tr></tbody></table>
###xml 658 659 624 625 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 740 741 704 705 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 659 886 625 850 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Additional experiments yielded similar results.</p>
###xml 658 886 624 850 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn1"><label>a</label><p textid="32">Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Additional experiments yielded similar results.</p></fn>
###xml 886 887 850 851 <label xmlns:xlink="http://www.w3.org/1999/xlink">b</label>
###xml 887 938 851 902 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Activity is due to 4-HBA in chorismate preparation.</p>
###xml 886 938 850 902 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn2"><label>b</label><p textid="33">Activity is due to 4-HBA in chorismate preparation.</p></fn>
###xml 658 938 624 902 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn1"><label>a</label><p textid="32">Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Additional experiments yielded similar results.</p></fn><fn id="tblfn2"><label>b</label><p textid="33">Activity is due to 4-HBA in chorismate preparation.</p></fn></table-wrap-foot>
###xml 0 938 0 902 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="31"><bold>Initial acyl substrate screen</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold>Activity</bold><xref ref-type="table-fn" rid="tblfn1"><bold><sup><italic>a</italic></sup></bold></xref></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol/min/mg</italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Phytohormones</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Indole-3-acetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.5 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Jasmonate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.9 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Gibberellate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Abscisate </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.8 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.1 &#177; 0.2 </td></tr></tbody><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Benzoates</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Benzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 59.6 &#177; 1.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylacetate </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.3 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Salicylate (2-hydroxybenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.7 &#177; 0.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;4-Hydroxybenzoate </td><td colspan="1" rowspan="1" align="center" valign="top"> 135.2 &#177; 8.6 </td></tr></tbody><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><bold>Chorismate pathway compounds</bold></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Chorismate<xref ref-type="table-fn" rid="tblfn2"><italic>b</italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 32.9 &#177; 2.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Prephenate </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.1 &#177; 0.4 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Anthranilate (2-aminobenzoate) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.7 &#177; 1.1 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Phenylalanine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tyrosine </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;Tryptophan </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0 &#177; 0.0 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> &#160;&#160;&#160;&#160;<italic>trans</italic>-Cinnamate </td><td colspan="1" rowspan="1" align="center" valign="top"> 21.3 &#177; 1.8 </td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p textid="32">Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Additional experiments yielded similar results.</p></fn><fn id="tblfn2"><label>b</label><p textid="33">Activity is due to 4-HBA in chorismate preparation.</p></fn></table-wrap-foot></table-wrap>
TABLE 1Initial acyl substrate screenActivityanmol/min/mgPhytohormones     Indole-3-acetate  1.5 +/- 0.1      Jasmonate  2.9 +/- 0.1      Gibberellate  0.1 +/- 0.1      Abscisate  0.8 +/- 0.1      Salicylate  1.7 +/- 0.1      INA  0.1 +/- 0.2 Benzoates     Benzoate  59.6 +/- 1.1      Phenylacetate  2.3 +/- 0.1      Salicylate (2-hydroxybenzoate)  1.7 +/- 0.1      4-Hydroxybenzoate  135.2 +/- 8.6 Chorismate pathway compounds     Chorismateb 32.9 +/- 2.0      Prephenate  10.1 +/- 0.4      Anthranilate (2-aminobenzoate)  0.7 +/- 1.1      Phenylalanine  0.0 +/- 0.0      Tyrosine  0.0 +/- 0.0      Tryptophan  0.0 +/- 0.0      trans-Cinnamate  21.3 +/- 1.8 aActivities are the mean of three replicates +/- 1 S.D. and are determined for 1 mm acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Additional experiments yielded similar results.bActivity is due to 4-HBA in chorismate preparation.
###end p 30
###begin p 31
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Initial acyl substrate screen</bold>
Initial acyl substrate screen
###end p 31
###begin p 32
###xml 81 82 79 80 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Activities are the mean of three replicates +/- 1 S.D. and are determined for 1 mm acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Additional experiments yielded similar results.
###end p 32
###begin p 33
Activity is due to 4-HBA in chorismate preparation.
###end p 33
###begin p 34
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 879 880 878 879 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 893 894 892 893 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1021 1022 1020 1021 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1184 1185 1177 1178 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Except for chorismate and prephenate, the acyl substrates on which PBS3 showed activity contain aromatic rings. Therefore, we sought to establish whether PBS3 is truly active on chorismate (and prephenate) or is active on breakdown products of these compounds. Known breakdown products of chorismate are phenyl pyruvate, prephenate, and 4-HBA (24-26). As shown in Table 1, PBS3 was highly active on 4-HBA with low activity on the nonaromatic prephenate (10.1 nmol/min/mg), and no significant activity on the aromatic breakdown product phenyl pyruvate. To determine whether the observed activity on chorismate and prephenate was because of 4-HBA contamination, we performed HPLC analysis on our freshly prepared chorismate and prephenate solutions. 4-HBA was present in our chorismate solution at a level sufficient to account for the observed PBS3 activity on chorismate (33.5 mum 4-HBA in 1 mm chorismate). Therefore, PBS3 does not appear to be active on chorismate. On the other hand, we did not detect 4-HBA in our 1 mm prephenate solution, even after incubation for 1 h under assay conditions (30 degreesC, pH 7.4). This suggests that the low adenylation activity of PBS3 with 1 mm prephenate is valid.
###end p 34
###begin p 35
###xml 167 174 167 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
To further examine the acyl substrate preference and specificity of PBS3, compounds structurally related to the active acyl substrates identified above were examined (Table 2). As PBS3 exhibited moderate activity on trans-cinnamate, we tested an additional series of cinnamic acids. We found that the parent compound trans-cinnamate PBS3 exhibited higher activity with than with any of the tested derivatives. As PBS3 exhibited significantly greater adenylation activity with 4-HBA and BA than with trans-cinnamate, we further investigated its substrate preference on substituted benzoates.
###end p 35
###begin p 36
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 2</label>
###xml 7 56 7 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Acyl substrate preference and specificity of PBS3</bold>
###xml 7 56 7 56 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><bold>Acyl substrate preference and specificity of PBS3</bold></p>
###xml 7 56 7 56 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><bold>Acyl substrate preference and specificity of PBS3</bold></p></caption>
###xml 56 56 56 56 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc018097165t002"/>
###xml 139 140 137 138 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 271 278 269 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 56 350 56 348 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">* Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Some compounds are repeated from <xref ref-type="table" rid="tbl1">Table 1</xref> for ease of comparison. Additional experiments yielded similar results.</p>
###xml 56 350 56 348 <fn xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">* Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Some compounds are repeated from <xref ref-type="table" rid="tbl1">Table 1</xref> for ease of comparison. Additional experiments yielded similar results.</p></fn>
###xml 56 350 56 348 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn><p textid="38">* Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Some compounds are repeated from <xref ref-type="table" rid="tbl1">Table 1</xref> for ease of comparison. Additional experiments yielded similar results.</p></fn></table-wrap-foot>
###xml 0 350 0 348 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl2"><label>TABLE 2</label><caption><p textid="37"><bold>Acyl substrate preference and specificity of PBS3</bold></p></caption><graphic xlink:href="zbc018097165t002"/><table-wrap-foot><fn><p textid="38">* Activities are the mean of three replicates &#177; 1 S.D. and are determined for 1 m<sc>m</sc> acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Some compounds are repeated from <xref ref-type="table" rid="tbl1">Table 1</xref> for ease of comparison. Additional experiments yielded similar results.</p></fn></table-wrap-foot></table-wrap>
TABLE 2Acyl substrate preference and specificity of PBS3* Activities are the mean of three replicates +/- 1 S.D. and are determined for 1 mm acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Some compounds are repeated from Table 1 for ease of comparison. Additional experiments yielded similar results.
###end p 36
###begin p 37
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Acyl substrate preference and specificity of PBS3</bold>
Acyl substrate preference and specificity of PBS3
###end p 37
###begin p 38
###xml 83 84 81 82 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 215 222 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
* Activities are the mean of three replicates +/- 1 S.D. and are determined for 1 mm acyl substrate using the coupled adenylation assay. Activities below 10 nmol/min/mg are minimal. Some compounds are repeated from Table 1 for ease of comparison. Additional experiments yielded similar results.
###end p 38
###begin p 39
###xml 0 70 0 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PBS3 Strongly Prefers para-Substituted Benzoates as the Acyl Substrate</italic>
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para</italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">meta-</italic>
###xml 502 503 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ortho</italic>
PBS3 Strongly Prefers para-Substituted Benzoates as the Acyl Substrate-We first examined the adenylation activity of PBS3 on mono-substituted benzoates substituted with hydroxyl (-OH) or amino (-NH2) groups at either the 2-, 3-, or 4-position (Table 2). The compounds on which PBS3 exhibited the highest velocity, 4-HBA (135.2 nmol/min/mg) and pABA (91.1 nmol/min/mg), are substituted at the para-position and were favored over BA. In contrast, substitution at the meta- position with either -OH or -NH2 resulted in significantly lowered PBS3 adenylation activity compared with BA, with adenylation activities of 13.3 and 11.5 nmol/min/mg for 3-HBA and 3-ABA, respectively. Finally, substitution at the ortho (2-) position was strongly disfavored with PBS3 exhibiting essentially no activity on SA or 2-ABA.
###end p 39
###begin p 40
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ortho</italic>
###xml 338 342 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">meta</italic>
###xml 477 483 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 541 547 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
We then investigated the impact of additional hydroxyl or methoxy (-MeO) substitutions on PBS3 adenylation activity (Table 2). Again para-hydroxyl-substituted benzoates were favored with ortho-hydroxyl-substituted benzoates strongly disfavored as follows: 4-HBA > BA > 3,4-DHBA > 3-HBA >> (SA; 3,4,5-THBA; 2,4-DHBA; and 2,3-DHBA). At the meta- position, MeO substitutions were preferred over additional hydroxyl substitutions. For both vanillate (4-hydroxy-3-methoxy benzoate) versus 3,4-DHBA and syringate (4-hydroxy-3,5-dimethoxybenzoate) versus gallate (3,4,5-trihydroxybenzoate), PBS3 exhibited at least 4-fold higher adenylation activity with the MeO compared with the hydroxyl substitutions. Additional modifications (hydroxyl substituents) to pABA also reduced PBS3 adenylation activity, with loss of activity associated with substitution at the 2-position. PBS3 activity was 91.1 nmol/min/mg with pABA (4-ABA) compared with 30.4 nmol/min/mg with 4-A-3HBA and 1.11 nmol/min/mg with 4-A-2HBA.
###end p 40
###begin p 41
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para-</italic>
###xml 241 248 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
To further examine the effect of different substituents at the para-position of benzoate, we compared the adenylation activities of PBS3 on 4-HBA, 4-fluorobenzoate, pABA, 4-amino-methylbenzoate (4-AMeBA), and 4-aminoethylbenzoate (4-AEtBA) (Table 2). The highest activity was observed on 4-HBA, with activity on pABA and 4-fluorobenzoate somewhat lower but still high, followed by a dramatic reduction in activity with the bulkier acyl substrates 4-AMeBA and 4-AEtBA.
###end p 41
###begin p 42
###xml 0 53 0 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PBS3 Catalyzes the Formation of Amino Acid Conjugates</italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">1</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">2</xref>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 970 971 970 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 964 971 964 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1133 1135 1133 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1576 1578 1576 1578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 1580 1582 1580 1582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">14</sub>
###xml 1584 1585 1584 1585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1592 1593 1592 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1594 1595 1594 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 1662 1663 1662 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1664 1665 1664 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 1701 1702 1701 1702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1703 1704 1703 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 1763 1764 1763 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 1765 1766 1765 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 1838 1839 1838 1839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1832 1839 1832 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1841 1846 1841 1846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">inset</italic>
###xml 2023 2025 2023 2025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 2027 2029 2027 2029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 2098 2099 2098 2099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 2105 2107 2105 2107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">13</sup>
###xml 2378 2386 2378 2386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
PBS3 Catalyzes the Formation of Amino Acid Conjugates-Once potential acyl substrates were identified, a subset was tested for conjugation to amino acids by recombinant PBS3. Because 4-HBA displayed the highest velocity in the adenylation assay (Tables 1 and 2), we first tested the ability of PBS3 to catalyze the conjugation of amino acids to 4-HBA. Of the 20 amino acids, TLC spots indicative of the 4-HBA-AA conjugate were reproducibly detected for reactions with Glu, His, and Lys, with a faint spot visible for Met (Fig. 2A). Very faint spots indicative of the amino acid conjugate were sometimes visible for reactions with Ile, Leu, Val, Thr, Ser, and Trp. A subset of these PBS3 reaction mixtures was then analyzed by HPLC to verify the presence of novel peaks consistent with the formation of specific 4-HBA-amino acid conjugates. Novel peaks indicative of 4-HBA-AA conjugate formation were observed by HPLC for reactions with Glu, His, Met, Thr, and Ser. Fig. 2B shows the chromatogram for the PBS3 reaction mixture with 4-HBA and Glu. The putative 4-HBA-Glu conjugate was only formed in the presence of PBS3 and required Mg2+ and ATP in the reaction mixture (data not shown). To verify the identity of 4-HBA-Glu, which is not commercially available, the fraction corresponding to the putative 4-HBA-Glu conjugate was collected and analyzed by LC-MS with electrospray ionization-positive ion analysis and by nanospray infusion Q-TOF MS with MS/MS. The mass spectrum of the putative 4-HBA-Glu conjugate is consistent with it being the protonated 4-HBA-Glu conjugate (C12 H14NO6) with m/z = 268.1. MS/MS analyses of the dominant ion peak (M + H) at 268.1 m/z result in major ion intensities at m/z = 251.0 consistent with loss of -OH, and fission products m/z = 130 and 121 likely associated with cleavage of the amide bond (Fig. 2B, inset). Our mass spectra data are similar to those reported for other benzoyl-amino acid conjugates in which fragments consistent with cleavage of the amide bond were also observed (27, 28). In addition, 4-HBA-Glu was chemically synthesized and analyzed by 1H and 13C NMR (see supplemental Methods S1). The chemically synthesized 4-HBA-Glu displayed identical HPLC retention time and UV spectral properties to the 4-HBA-Glu from enzymatic reactions catalyzed by PBS3. This further confirms that PBS3 catalyzes the formation of 4-HBA-Glu in vitro.
###end p 42
###begin p 43
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 221 228 221 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">f</sub>
###xml 235 237 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R<sub>f</sub></italic>
Conjugation of pABA by PBS3 was also tested with the 20 amino acids and monitored by TLC. Unlike the results with 4-HBA, only a spot for pABA-Glu was detected either by UV light (similarly to 4-HBA) or vanillin staining (Fig. 2C). The Rf value of this putative pABA-Glu conjugate was similar to that of the commercially available standard. pABA-Glu formation by PBS3 was also followed by HPLC. The conversion of pABA to pABA-Glu occurred only with PBS3 in the reaction mixture. As PBS3 also formed additional amino acid conjugates with 4-HBA, we confirmed that similar amino acids conjugates were not formed with pABA by analyzing a subset of these reactions by HPLC. We did not detect putative pABA-His, pABA-Met, or pABA-Ser peaks by HPLC (data not shown).
###end p 43
###begin p 44
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 296 303 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 1088 1092 1088 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
Other compounds with high velocity (BA and vanillate), moderate velocity (trans-cinnamate), and minimal velocity (SA) were also tested as acyl substrates in the Glu conjugation reaction. TLC analyses showed that recombinant PBS3 catalyzed the conjugation of Glu to vanillate and trans-cinnamate (Fig. 2D) but not to SA. As none of a variety of stains tested worked satisfactorily for BA, we assessed the BA reaction mixture by HPLC. We detected formation of the BA-Glu conjugate from BA and Glu by PBS3, with commercially available BA and BA-Glu used as standards. To further confirm that PBS3 was unable to form the SA-Glu conjugate, we assessed the SA reaction mixture by HPLC. Although SA was readily detected by fluorescence, no novel peaks indicative of SA-Glu were apparent. These results validate the use of the adenylation assay to study substrate specificity by confirming that those acyl substrates with high velocity in the adenylation assay were also capable of forming amino acid conjugates, whereas those substrates with essentially no activity using the adenylation assay (e.g. SA) were not.
###end p 44
###begin p 45
###xml 62 63 62 63 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 296 297 296 297 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 313 314 313 314 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 335 336 335 336 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 390 391 382 383 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 432 433 424 425 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 538 539 522 523 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 630 631 606 607 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 717 718 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 711 718 687 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>E</italic></xref>
We found that 4-HBA and pABA conjugates were formed with Glu (l-glutamic acid) but not Asp. In addition, with pABA as the acyl substrate, pABA-Glu was the only amino acid conjugate detected. Therefore, we wanted to further examine the specificity of PBS3 for Glu. We tested the related compounds d-glutamic acid, l-2-aminoadipic acid, l-glutamic acid gamma-methyl ester, and gamma-carboxyl l-glutamic acid in our conjugation assay. l-2-Aminoadipic acid contains an additional carbon between the alpha-carbon and the gamma-carboxyl group; l-glutamic acid gamma-methyl ester lacks a second carboxylic acid group, and gamma-carboxyl l-glutamic acid contains a third carboxylic acid group. PBS3 did not form 4-HBA (Fig. 2E) or pABA conjugates (not shown) with these glutamic acid derivatives.
###end p 45
###begin p 46
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 94 9 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.</bold>
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 159 161 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset,</italic>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 361 363 361 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 557 559 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VA</italic>
###xml 572 578 572 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans-</italic>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t-CA</italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 680 686 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans-</italic>
###xml 705 707 705 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E,</italic>
###xml 765 769 765 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAD,</italic>
###xml 769 770 769 770 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 791 794 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gla</italic>
###xml 811 812 807 808 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 828 833 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MeGlu</italic>
###xml 835 836 831 832 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 9 1078 9 1070 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47"><bold>PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.</bold><italic>A,</italic> TLC analysis of 4-HBA amino acid conjugate formation by PBS3. <italic>B,</italic> HPLC analysis of 4-HBA-Glu formation by PBS3. <italic>Inset,</italic> verification of putative 4-HBA-Glu peak by LC-MS. Shown is Q-TOF MS/MS on <italic>m</italic>/<italic>z</italic> = 268.1 with 4-HBA-Glu structure. Likely fission site is indicated. <italic>C,</italic> TLC analysis of pABA-Glu formation by PBS3 as follows: pABA standard (<italic>left</italic>), reaction mixture (<italic>middle</italic>), and pABA-Glu standard (<italic>right</italic>). <italic>D,</italic> TLC analysis of the PBS3 reactions with vanillic acid (<italic>VA</italic>), 4-HBA, or <italic>trans-</italic>cinnamic acid (<italic>t-CA</italic>) as the acyl substrate and Glu. The <italic>arrow</italic> indicates a faint spot corresponding to <italic>trans-</italic>cinnamic acid-Glu. <italic>E,</italic> TLC of the PBS3 reaction with 4-HBA and Glu derivatives. <italic>AAD,</italic><sc>l</sc>-2-aminoadipic acid; <italic>Gla</italic>, &#947;-carboxyl <sc>l</sc>-glutamic acid; <italic>MeGlu</italic>, <sc>l</sc>-gutamic acid &#947;-methyl ester. Images of TLC plates were converted to grayscale and adjustments of &#8220;levels&#8221; in Photoshop were performed. Independent experiments with different batches of purified, recombinant PBS3 produced similar results.</p>
###xml 9 1078 9 1070 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="47"><bold>PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.</bold><italic>A,</italic> TLC analysis of 4-HBA amino acid conjugate formation by PBS3. <italic>B,</italic> HPLC analysis of 4-HBA-Glu formation by PBS3. <italic>Inset,</italic> verification of putative 4-HBA-Glu peak by LC-MS. Shown is Q-TOF MS/MS on <italic>m</italic>/<italic>z</italic> = 268.1 with 4-HBA-Glu structure. Likely fission site is indicated. <italic>C,</italic> TLC analysis of pABA-Glu formation by PBS3 as follows: pABA standard (<italic>left</italic>), reaction mixture (<italic>middle</italic>), and pABA-Glu standard (<italic>right</italic>). <italic>D,</italic> TLC analysis of the PBS3 reactions with vanillic acid (<italic>VA</italic>), 4-HBA, or <italic>trans-</italic>cinnamic acid (<italic>t-CA</italic>) as the acyl substrate and Glu. The <italic>arrow</italic> indicates a faint spot corresponding to <italic>trans-</italic>cinnamic acid-Glu. <italic>E,</italic> TLC of the PBS3 reaction with 4-HBA and Glu derivatives. <italic>AAD,</italic><sc>l</sc>-2-aminoadipic acid; <italic>Gla</italic>, &#947;-carboxyl <sc>l</sc>-glutamic acid; <italic>MeGlu</italic>, <sc>l</sc>-gutamic acid &#947;-methyl ester. Images of TLC plates were converted to grayscale and adjustments of &#8220;levels&#8221; in Photoshop were performed. Independent experiments with different batches of purified, recombinant PBS3 produced similar results.</p></caption>
###xml 1078 1078 1070 1070 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0180971650002"/>
###xml 0 1078 0 1070 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="47"><bold>PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.</bold><italic>A,</italic> TLC analysis of 4-HBA amino acid conjugate formation by PBS3. <italic>B,</italic> HPLC analysis of 4-HBA-Glu formation by PBS3. <italic>Inset,</italic> verification of putative 4-HBA-Glu peak by LC-MS. Shown is Q-TOF MS/MS on <italic>m</italic>/<italic>z</italic> = 268.1 with 4-HBA-Glu structure. Likely fission site is indicated. <italic>C,</italic> TLC analysis of pABA-Glu formation by PBS3 as follows: pABA standard (<italic>left</italic>), reaction mixture (<italic>middle</italic>), and pABA-Glu standard (<italic>right</italic>). <italic>D,</italic> TLC analysis of the PBS3 reactions with vanillic acid (<italic>VA</italic>), 4-HBA, or <italic>trans-</italic>cinnamic acid (<italic>t-CA</italic>) as the acyl substrate and Glu. The <italic>arrow</italic> indicates a faint spot corresponding to <italic>trans-</italic>cinnamic acid-Glu. <italic>E,</italic> TLC of the PBS3 reaction with 4-HBA and Glu derivatives. <italic>AAD,</italic><sc>l</sc>-2-aminoadipic acid; <italic>Gla</italic>, &#947;-carboxyl <sc>l</sc>-glutamic acid; <italic>MeGlu</italic>, <sc>l</sc>-gutamic acid &#947;-methyl ester. Images of TLC plates were converted to grayscale and adjustments of &#8220;levels&#8221; in Photoshop were performed. Independent experiments with different batches of purified, recombinant PBS3 produced similar results.</p></caption><graphic xlink:href="zbc0180971650002"/></fig>
FIGURE 2.PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.A, TLC analysis of 4-HBA amino acid conjugate formation by PBS3. B, HPLC analysis of 4-HBA-Glu formation by PBS3. Inset, verification of putative 4-HBA-Glu peak by LC-MS. Shown is Q-TOF MS/MS on m/z = 268.1 with 4-HBA-Glu structure. Likely fission site is indicated. C, TLC analysis of pABA-Glu formation by PBS3 as follows: pABA standard (left), reaction mixture (middle), and pABA-Glu standard (right). D, TLC analysis of the PBS3 reactions with vanillic acid (VA), 4-HBA, or trans-cinnamic acid (t-CA) as the acyl substrate and Glu. The arrow indicates a faint spot corresponding to trans-cinnamic acid-Glu. E, TLC of the PBS3 reaction with 4-HBA and Glu derivatives. AAD,l-2-aminoadipic acid; Gla, gamma-carboxyl l-glutamic acid; MeGlu, l-gutamic acid gamma-methyl ester. Images of TLC plates were converted to grayscale and adjustments of "levels" in Photoshop were performed. Independent experiments with different batches of purified, recombinant PBS3 produced similar results.
###end p 46
###begin p 47
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.</bold>
###xml 85 87 85 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 150 152 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B,</italic>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset,</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">z</italic>
###xml 352 354 352 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C,</italic>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 490 492 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D,</italic>
###xml 548 550 548 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VA</italic>
###xml 563 569 563 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans-</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t-CA</italic>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 671 677 671 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans-</italic>
###xml 696 698 696 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E,</italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAD,</italic>
###xml 760 761 760 761 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 782 785 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gla</italic>
###xml 802 803 798 799 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 819 824 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MeGlu</italic>
###xml 826 827 822 823 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
PBS3 catalyzes the formation of amino acid conjugates with preferred acyl substrates.A, TLC analysis of 4-HBA amino acid conjugate formation by PBS3. B, HPLC analysis of 4-HBA-Glu formation by PBS3. Inset, verification of putative 4-HBA-Glu peak by LC-MS. Shown is Q-TOF MS/MS on m/z = 268.1 with 4-HBA-Glu structure. Likely fission site is indicated. C, TLC analysis of pABA-Glu formation by PBS3 as follows: pABA standard (left), reaction mixture (middle), and pABA-Glu standard (right). D, TLC analysis of the PBS3 reactions with vanillic acid (VA), 4-HBA, or trans-cinnamic acid (t-CA) as the acyl substrate and Glu. The arrow indicates a faint spot corresponding to trans-cinnamic acid-Glu. E, TLC of the PBS3 reaction with 4-HBA and Glu derivatives. AAD,l-2-aminoadipic acid; Gla, gamma-carboxyl l-glutamic acid; MeGlu, l-gutamic acid gamma-methyl ester. Images of TLC plates were converted to grayscale and adjustments of "levels" in Photoshop were performed. Independent experiments with different batches of purified, recombinant PBS3 produced similar results.
###end p 47
###begin p 48
###xml 0 109 0 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Point Mutations in the C Terminus of PBS3 Present in the pbs3-1 Mutant Result in Loss of Biochemical Activity</italic>
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 374 385 374 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 638 649 630 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 1356 1363 1348 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1503 1509 1495 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
###xml 1534 1540 1526 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-2</italic>
###xml 1565 1566 1557 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 374 385 <span type="species:ncbi:317">P. syringae</span>
Point Mutations in the C Terminus of PBS3 Present in the pbs3-1 Mutant Result in Loss of Biochemical Activity-The pbs3-1 EMS mutant contains two amino acid substitutions in highly conserved amino acids at the C terminus (E502K and I519T) (3). This portion of the PBS3 protein has no known motifs and is contained within the region of PBS3 (amino acids 335-575) bound by the P. syringae HopW1-1 effector (18). Glu-502 is predicted to be within an alpha-helix, whereas residue Ile-519 is predicted to reside in a loop region following the aforementioned alpha-helix (supplemental Fig. S2). The high degree of conservation of Ile-519 in all Arabidopsis GH3 proteins (Ile in all but two GH3s which have a Val at this position) suggests it does not confer substrate specificity; however, it could play a more general role in substrate binding or in catalysis. To ascertain the impact of these mutations on PBS3 activity, we expressed and purified recombinant enzyme with either or both of the mutations and compared its activity with the wild type recombinant enzyme. We found that the single and double mutations resulted in a complete loss of activity (<0.5 nmol/min/mg) as measured by the adenylation assay with 4-HBA, pABA, or BA as acyl substrates. Wild type recombinant PBS3 exhibited activity similar to that found with previous enzyme preparations (see Table 2). The loss of biochemical activity associated with these mutations is consistent with the similar phenotypes we observed for the recessive pbs3-1 EMS mutant and the null pbs3-2 T-DNA insertion mutant (3).
###end p 48
###begin p 49
###xml 0 40 0 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kinetic and Catalytic Properties of PBS3</italic>
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Kinetic and Catalytic Properties of PBS3-Similar to other characterized GH3 enzymes, the exclusion of Mg2+ or ATP from the reaction mixture resulted in loss of PBS3 activity (data not shown). To determine the pH requirements of the reaction, we performed TLC analyses on the reaction mixtures using either pABA or vanillate as the acyl substrate with Glu as the amino acid at pH 7.5, 8.0, and 8.5. Clearly visible products were observed for the reactions at pH 8.0 and 8.5 but not at pH 7.5 (data not shown).
###end p 49
###begin p 50
###xml 288 289 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sub>m</sub></italic>
###xml 514 515 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sub>m</sub></italic>
###xml 533 534 532 533 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 558 559 556 557 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 606 607 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 606 607 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sub>m</sub></italic>
###xml 688 690 686 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 836 843 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1023 1024 1021 1022 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1023 1024 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sub>m</sub></italic>
###xml 1033 1034 1030 1031 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1057 1058 1054 1055 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1056 1058 1053 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1067 1068 1063 1064 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1079 1080 1075 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1078 1080 1074 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1089 1090 1084 1085 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1097 1098 1092 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1098 1101 1093 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 1156 1158 1151 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1214 1216 1209 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1305 1306 1299 1300 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1306 1308 1300 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1312 1314 1306 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1404 1405 1397 1398 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1405 1407 1398 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1411 1413 1404 1406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1496 1497 1489 1490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1495 1497 1488 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1528 1529 1520 1521 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1545 1546 1537 1538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1546 1549 1538 1541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 1585 1587 1577 1579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
To further characterize the PBS3 benzoyl amino acid synthetase reaction, we determined its kinetic properties using the following three biologically relevant acyl substrates with the highest adenylation activity: 4-HBA, pABA, and BA. For these analyses, we first determined the apparent Km value for ATP using 4-HBA and pABA as acyl substrates to ensure we used sufficient ATP in our kinetic assays. Using the coupled adenylation assay, we found PBS3 exhibited standard Michaelis-Menten kinetics with an apparent Km for ATP of 791 mum (with 4-HBA) and 636 mum (with pABA). We then determined the apparent Km of PBS3 for the acyl substrates 4-HBA, pABA, and BA at pH 8.5 with saturating Mg2+, ATP, and Glu. The concentration of the Glu conjugate produced in the reactions was quantified by HPLC over time, with the results summarized in Table 3. With all three acyl substrates, we found PBS3 exhibited standard Michaelis-Menten kinetics. The corresponding Hanes plots indicated that PBS3 had the highest affinity for pABA (Km = 153 mum), followed by 4-HBA (Km = 459 mum) and BA (Km = 867 mum). The kcat values for pABA and BA were similar (2.74 and 3.96 min-1), whereas that for 4-HBA was 5-7-fold higher (20.36 min-1). PBS3 exhibited similar catalytic efficiencies for 4-HBA and pABA (0.0444 and 0.0179 mum-1 min-1, respectively) with reduced catalytic efficiency with BA as the acyl substrate (0.0046 mum-1 min-1). Nonlinear curve fitting of our kinetic data gave similar results with apparent Km values of 460, 120, and 931 mum and calculated kcat values of 20.83, 2.70, and 4.06 min-1 for 4-HBA, pABA, and BA, respectively.
###end p 50
###begin p 51
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 3</label>
###xml 7 44 7 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetic parameters of PBS3 substrates</bold>
###xml 7 44 7 44 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52"><bold>Kinetic parameters of PBS3 substrates</bold></p>
###xml 44 214 44 214 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="53">Kinetic constants were determined by following acyl substrate-Glu formation by HPLC. Similar results were obtained for experiments with an independent enzyme preparation.</p>
###xml 7 214 7 214 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52"><bold>Kinetic parameters of PBS3 substrates</bold></p><p textid="53">Kinetic constants were determined by following acyl substrate-Glu formation by HPLC. Similar results were obtained for experiments with an independent enzyme preparation.</p></caption>
###xml 214 228 214 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Acyl substrate</bold>
###xml 214 228 214 228 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Acyl substrate</bold></th>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 229 232 229 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 228 232 228 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic><sub>cat</sub></bold>
###xml 228 232 228 232 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub></bold></th>
###xml 233 234 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 232 234 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 232 234 232 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>m</sub></italic></bold>
###xml 232 234 232 234 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 235 238 235 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 240 241 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 234 241 234 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic></bold>
###xml 234 241 234 241 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic></bold></th>
###xml 214 241 214 241 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Acyl substrate</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic></bold></th></tr>
###xml 214 241 214 241 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Acyl substrate</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic></bold></th></tr></thead>
###xml 241 241 241 241 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 244 246 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">min<sup>-1</sup></italic>
###xml 241 246 241 246 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic></td>
###xml 249 250 248 249 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 249 250 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 246 250 246 249 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 253 255 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 250 255 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">min<sup>-1</sup></italic>
###xml 258 259 256 257 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 259 261 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 258 261 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc><sup>-1</sup></italic>
###xml 250 261 249 259 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic> &#956;<italic><sc>m</sc><sup>-1</sup></italic></td>
###xml 241 261 241 259 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic> &#956;<italic><sc>m</sc><sup>-1</sup></italic></td></tr>
###xml 261 268 259 266 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 4-HBA </td>
###xml 268 275 266 273 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 20.36 </td>
###xml 275 280 273 278 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 459 </td>
###xml 280 288 278 286 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.0444 </td>
###xml 261 288 259 286 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 4-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 20.36 </td><td colspan="1" rowspan="1" align="center" valign="top"> 459 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0444 </td></tr>
###xml 288 294 286 292 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pABA </td>
###xml 294 300 292 298 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.74 </td>
###xml 300 305 298 303 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 153 </td>
###xml 305 313 303 311 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.0179 </td>
###xml 288 313 286 311 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pABA </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.74 </td><td colspan="1" rowspan="1" align="center" valign="top"> 153 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0179 </td></tr>
###xml 313 317 311 315 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> BA </td>
###xml 317 323 315 321 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 3.96 </td>
###xml 323 328 321 326 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 867 </td>
###xml 328 336 326 334 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.0046 </td>
###xml 313 336 311 334 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> BA </td><td colspan="1" rowspan="1" align="center" valign="top"> 3.96 </td><td colspan="1" rowspan="1" align="center" valign="top"> 867 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0046 </td></tr>
###xml 241 336 241 334 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic> &#956;<italic><sc>m</sc><sup>-1</sup></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 4-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 20.36 </td><td colspan="1" rowspan="1" align="center" valign="top"> 459 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0444 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pABA </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.74 </td><td colspan="1" rowspan="1" align="center" valign="top"> 153 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0179 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BA </td><td colspan="1" rowspan="1" align="center" valign="top"> 3.96 </td><td colspan="1" rowspan="1" align="center" valign="top"> 867 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0046 </td></tr></tbody>
###xml 214 336 214 334 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Acyl substrate</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic></bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic> &#956;<italic><sc>m</sc><sup>-1</sup></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 4-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 20.36 </td><td colspan="1" rowspan="1" align="center" valign="top"> 459 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0444 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pABA </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.74 </td><td colspan="1" rowspan="1" align="center" valign="top"> 153 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0179 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BA </td><td colspan="1" rowspan="1" align="center" valign="top"> 3.96 </td><td colspan="1" rowspan="1" align="center" valign="top"> 867 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0046 </td></tr></tbody></table>
###xml 0 336 0 334 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl3"><label>TABLE 3</label><caption><p textid="52"><bold>Kinetic parameters of PBS3 substrates</bold></p><p textid="53">Kinetic constants were determined by following acyl substrate-Glu formation by HPLC. Similar results were obtained for experiments with an independent enzyme preparation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Acyl substrate</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>k</italic><sub>cat</sub>/<italic>K<sub>m</sub></italic></bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>min<sup>-1</sup></italic> &#956;<italic><sc>m</sc><sup>-1</sup></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 4-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 20.36 </td><td colspan="1" rowspan="1" align="center" valign="top"> 459 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0444 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pABA </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.74 </td><td colspan="1" rowspan="1" align="center" valign="top"> 153 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0179 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BA </td><td colspan="1" rowspan="1" align="center" valign="top"> 3.96 </td><td colspan="1" rowspan="1" align="center" valign="top"> 867 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.0046 </td></tr></tbody></table></table-wrap>
TABLE 3Kinetic parameters of PBS3 substratesKinetic constants were determined by following acyl substrate-Glu formation by HPLC. Similar results were obtained for experiments with an independent enzyme preparation.Acyl substratekcatKmkcat/Kmmin-1 mummin-1 mum-1 4-HBA  20.36  459  0.0444  pABA  2.74  153  0.0179  BA  3.96  867  0.0046 
###end p 51
###begin p 52
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetic parameters of PBS3 substrates</bold>
Kinetic parameters of PBS3 substrates
###end p 52
###begin p 53
Kinetic constants were determined by following acyl substrate-Glu formation by HPLC. Similar results were obtained for experiments with an independent enzyme preparation.
###end p 53
###begin p 54
###xml 0 93 0 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Does PBS3 Impact SA Metabolism by Altering the Enzymatic Activity of SA Biosynthetic Enzymes?</italic>
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3</italic>
###xml 466 477 466 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. thaliana</italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 973 986 973 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa</italic>
###xml 1035 1048 1035 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa</italic>
###xml 1114 1124 1114 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsi</italic>
###xml 1200 1201 1200 1201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1199 1201 1199 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1349 1351 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1442 1443 1441 1442 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1511 1512 1510 1511 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 466 477 <span type="species:ncbi:3702">A. thaliana</span>
###xml 973 986 <span type="species:ncbi:444978|species:ncbi:287">P. aeruginosa</span>
###xml 1035 1048 <span type="species:ncbi:444978|species:ncbi:287">P. aeruginosa</span>
Does PBS3 Impact SA Metabolism by Altering the Enzymatic Activity of SA Biosynthetic Enzymes?-One potential manner by which PBS3 could impact SA metabolism is by altering the enzymatic activity of SA biosynthetic enzymes. As the pbs3 mutants appear to be compromised in SA biosynthesis, if this hypothesis is correct, we would expect the following: 1) PBS3 substrate(s) inhibit SA biosynthetic activity and/or 2) PBS3 product(s) activate SA biosynthetic enzymes. In A. thaliana, pathogen-induced SA biosynthesis requires the inducible isochorismate synthase AtICS1 (29). AtICS1 catalyzes the reversible conversion of chorismate to isochorismate (22). Isochorismate is likely then converted to SA by an IPL with the concomitant release of pyruvate, as it is in bacteria that synthesize SA (23, 30). Therefore, we wanted to determine whether the PBS3 substrates 4-HBA or pABA or the PBS3 product pABA-Glu impacts the activity of known SA biosynthetic enzymes (AtICS1 and the P. aeruginosa isochorismate pyruvate lyase PchB). We used the P. aeruginosa PchB enzyme as a surrogate for a putative, yet-to-be identified, Arabidopsis IPL. All assessments were performed with substrate concentrations at the Km value for the respective enzyme. We employed a coupled spectrophotometric assay to assess the conversion of chorismate to isochorismate by AtICS1 (22) and found no statistically significant difference in activity with the addition of 200 mum 4-HBA, pABA, or pABA-Glu. This was also true when assessed with 1 mm 4-HBA, pABA, or pABA-Glu. Furthermore, we found that the conversion of isochorismate to SA by PchB was also unaffected by these compounds.
###end p 54
###begin p 55
###xml 0 63 0 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PBS3 Activity Is Inhibited by SA but Not by Other Phytohormones</italic>
###xml 359 365 359 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 455 457 455 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 466 467 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 604 605 602 603 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 616 618 614 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
PBS3 Activity Is Inhibited by SA but Not by Other Phytohormones-As PBS3 impacts SA metabolism and the most active acyl substrates of PBS3 are structurally similar to SA, we then sought to determine whether SA could inhibit PBS3 activity. To test this, we assayed the effect of increasing concentrations of SA on PBS3-catalyzed pABA-Glu formation. As shown in Fig. 3, SA dramatically reduced the amino acid conjugation activity of PBS3 with an estimated IC50 of 15 mum. To determine whether the inhibition of PBS3 by SA was competitive, we added excess (saturating) pABA to the reaction mixture with 15 mum SA (the IC50). Full activity with maximal velocity was restored (data not shown). This suggests that SA acts as a competitive inhibitor of PBS3 activity.
###end p 55
###begin p 56
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 43 9 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of PBS3 activity by SA.</bold>
###xml 218 219 217 218 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 233 234 232 233 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 288 9 287 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="57"><bold>Inhibition of PBS3 activity by SA.</bold> SA inhibits the formation of pABA-Glu catalyzed by PBS3. The reaction velocities were determined by monitoring the formation of pABA-Glu by HPLC of PBS3 reactions with 150 &#956;<sc>m</sc> pABA and 10 m<sc>m</sc> Glu. Independent experiments yielded similar results.</p>
###xml 9 288 9 287 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="57"><bold>Inhibition of PBS3 activity by SA.</bold> SA inhibits the formation of pABA-Glu catalyzed by PBS3. The reaction velocities were determined by monitoring the formation of pABA-Glu by HPLC of PBS3 reactions with 150 &#956;<sc>m</sc> pABA and 10 m<sc>m</sc> Glu. Independent experiments yielded similar results.</p></caption>
###xml 288 288 287 287 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0180971650003"/>
###xml 0 288 0 287 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="57"><bold>Inhibition of PBS3 activity by SA.</bold> SA inhibits the formation of pABA-Glu catalyzed by PBS3. The reaction velocities were determined by monitoring the formation of pABA-Glu by HPLC of PBS3 reactions with 150 &#956;<sc>m</sc> pABA and 10 m<sc>m</sc> Glu. Independent experiments yielded similar results.</p></caption><graphic xlink:href="zbc0180971650003"/></fig>
FIGURE 3.Inhibition of PBS3 activity by SA. SA inhibits the formation of pABA-Glu catalyzed by PBS3. The reaction velocities were determined by monitoring the formation of pABA-Glu by HPLC of PBS3 reactions with 150 mum pABA and 10 mm Glu. Independent experiments yielded similar results.
###end p 56
###begin p 57
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of PBS3 activity by SA.</bold>
###xml 209 210 208 209 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 224 225 223 224 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Inhibition of PBS3 activity by SA. SA inhibits the formation of pABA-Glu catalyzed by PBS3. The reaction velocities were determined by monitoring the formation of pABA-Glu by HPLC of PBS3 reactions with 150 mum pABA and 10 mm Glu. Independent experiments yielded similar results.
###end p 57
###begin p 58
###xml 243 244 242 243 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 289 290 287 288 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 315 322 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl4">Table 4</xref>
###xml 592 593 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 734 741 732 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl4">Table 4</xref>
We then sought to determine whether 3-HBA or phytohormones, including MeSA (the mobile ester of SA) and the SA functional analog INA, could modulate PBS3 activity. For this, we used our high throughput adenylation assay. With this assay, 30 mum SA inhibited PBS3 activity by 33% and 300 mum SA inhibited it by 75% (Table 4). Although this observed inhibition was of reduced magnitude compared with that found using the full HPLC assay, we verified that the inhibition was due to the impact of SA on PBS3 activity by confirming that SA had no effect on activity of the coupling enzymes with PPi as the substrate. Of the six compounds tested, we found that only SA and the SA functional analog INA dramatically inhibited PBS3 activity (Table 4). IAA, JA, MeSA, and 3-HBA did not substantially inhibit PBS3 activity.
###end p 58
###begin p 59
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 4</label>
###xml 7 50 7 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fractional inhibition of pABA-AMP formation</bold>
###xml 7 50 7 50 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="60"><bold>Fractional inhibition of pABA-AMP formation</bold></p>
###xml 7 50 7 50 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="60"><bold>Fractional inhibition of pABA-AMP formation</bold></p></caption>
###xml 50 58 50 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Compound</bold>
###xml 50 58 50 58 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Compound</bold></th>
###xml 58 79 58 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fractional inhibition</bold>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sup>
###xml 79 80 79 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup><italic>a</italic></sup></bold>
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><bold><sup><italic>a</italic></sup></bold></xref>
###xml 86 87 85 86 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 80 88 80 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(30 &#956;<sc>m</sc>)</bold>
###xml 58 88 58 87 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition</bold><xref ref-type="table-fn" rid="tblfn3"><bold><sup><italic>a</italic></sup></bold></xref><bold>(30 &#956;<sc>m</sc>)</bold></th>
###xml 117 118 115 116 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 88 119 87 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fractional inhibition (300 &#956;<sc>m</sc>)</bold>
###xml 88 119 87 117 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition (300 &#956;<sc>m</sc>)</bold></th>
###xml 50 119 50 117 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Compound</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition</bold><xref ref-type="table-fn" rid="tblfn3"><bold><sup><italic>a</italic></sup></bold></xref><bold>(30 &#956;<sc>m</sc>)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition (300 &#956;<sc>m</sc>)</bold></th></tr>
###xml 50 119 50 117 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Compound</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition</bold><xref ref-type="table-fn" rid="tblfn3"><bold><sup><italic>a</italic></sup></bold></xref><bold>(30 &#956;<sc>m</sc>)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition (300 &#956;<sc>m</sc>)</bold></th></tr></thead>
###xml 119 123 117 121 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> SA </td>
###xml 123 129 121 127 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.33 </td>
###xml 129 135 127 133 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.75 </td>
###xml 119 135 117 133 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> SA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.75 </td></tr>
###xml 135 141 133 139 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> MeSA </td>
###xml 141 147 139 145 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td>
###xml 147 153 145 151 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.00 </td>
###xml 135 153 133 151 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> MeSA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.00 </td></tr>
###xml 153 158 151 156 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> INA </td>
###xml 158 164 156 162 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.09 </td>
###xml 164 170 162 168 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.70 </td>
###xml 153 170 151 168 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.09 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.70 </td></tr>
###xml 170 175 168 173 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> IAA </td>
###xml 175 181 173 179 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td>
###xml 181 187 179 185 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.19 </td>
###xml 170 187 168 185 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> IAA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.19 </td></tr>
###xml 187 191 185 189 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> JA </td>
###xml 191 197 189 195 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td>
###xml 197 203 195 201 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.10 </td>
###xml 187 203 185 201 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> JA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.10 </td></tr>
###xml 203 210 201 208 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 3-HBA </td>
###xml 210 216 208 214 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td>
###xml 216 222 214 220 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.22 </td>
###xml 203 222 201 220 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> 3-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.22 </td></tr>
###xml 119 222 117 220 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"> SA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.75 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> MeSA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.00 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.09 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.70 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> IAA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.19 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> JA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 3-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.22 </td></tr></tbody>
###xml 50 222 50 220 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Compound</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition</bold><xref ref-type="table-fn" rid="tblfn3"><bold><sup><italic>a</italic></sup></bold></xref><bold>(30 &#956;<sc>m</sc>)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition (300 &#956;<sc>m</sc>)</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> SA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.75 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> MeSA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.00 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.09 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.70 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> IAA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.19 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> JA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 3-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.22 </td></tr></tbody></table>
###xml 222 223 220 221 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 380 381 377 378 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 425 426 421 422 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 223 526 221 522 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="61">Fractional inhibition compares activity with additional compound to control reaction. Inhibition was assessed using the coupled adenylation assay with 150 &#956;<sc>m</sc> pABA as the acyl substrate and 30 or 300 &#956;<sc>m</sc> of the compound being tested. Repeat experiments with a separate enzyme batch gave similar results.</p>
###xml 222 526 220 522 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn3"><label>a</label><p textid="61">Fractional inhibition compares activity with additional compound to control reaction. Inhibition was assessed using the coupled adenylation assay with 150 &#956;<sc>m</sc> pABA as the acyl substrate and 30 or 300 &#956;<sc>m</sc> of the compound being tested. Repeat experiments with a separate enzyme batch gave similar results.</p></fn>
###xml 222 526 220 522 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn3"><label>a</label><p textid="61">Fractional inhibition compares activity with additional compound to control reaction. Inhibition was assessed using the coupled adenylation assay with 150 &#956;<sc>m</sc> pABA as the acyl substrate and 30 or 300 &#956;<sc>m</sc> of the compound being tested. Repeat experiments with a separate enzyme batch gave similar results.</p></fn></table-wrap-foot>
###xml 0 526 0 522 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl4"><label>TABLE 4</label><caption><p textid="60"><bold>Fractional inhibition of pABA-AMP formation</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Compound</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition</bold><xref ref-type="table-fn" rid="tblfn3"><bold><sup><italic>a</italic></sup></bold></xref><bold>(30 &#956;<sc>m</sc>)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Fractional inhibition (300 &#956;<sc>m</sc>)</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> SA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.75 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> MeSA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.00 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> INA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.09 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.70 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> IAA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.19 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> JA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.02 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> 3-HBA </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.04 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.22 </td></tr></tbody></table><table-wrap-foot><fn id="tblfn3"><label>a</label><p textid="61">Fractional inhibition compares activity with additional compound to control reaction. Inhibition was assessed using the coupled adenylation assay with 150 &#956;<sc>m</sc> pABA as the acyl substrate and 30 or 300 &#956;<sc>m</sc> of the compound being tested. Repeat experiments with a separate enzyme batch gave similar results.</p></fn></table-wrap-foot></table-wrap>
TABLE 4Fractional inhibition of pABA-AMP formationCompoundFractional inhibitiona(30 mum)Fractional inhibition (300 mum) SA  0.33  0.75  MeSA  0.02  0.00  INA  0.09  0.70  IAA  0.04  0.19  JA  0.02  0.10  3-HBA  0.04  0.22 aFractional inhibition compares activity with additional compound to control reaction. Inhibition was assessed using the coupled adenylation assay with 150 mum pABA as the acyl substrate and 30 or 300 mum of the compound being tested. Repeat experiments with a separate enzyme batch gave similar results.
###end p 59
###begin p 60
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fractional inhibition of pABA-AMP formation</bold>
Fractional inhibition of pABA-AMP formation
###end p 60
###begin p 61
###xml 157 158 156 157 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 202 203 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Fractional inhibition compares activity with additional compound to control reaction. Inhibition was assessed using the coupled adenylation assay with 150 mum pABA as the acyl substrate and 30 or 300 mum of the compound being tested. Repeat experiments with a separate enzyme batch gave similar results.
###end p 61
###begin title 62
DISCUSSION
###end title 62
###begin p 63
###xml 0 53 0 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insights into PBS3 Active Site and Reaction Mechanism</italic>
###xml 351 353 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 508 510 508 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 684 685 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 685 686 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 724 725 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 723 725 719 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>a</sub></italic>
###xml 825 827 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
Insights into PBS3 Active Site and Reaction Mechanism-The GH3 enzymes differ from other members of the acyl-adenylate/thioester-forming superfamily in that amino acid conjugation occurs directly to the acyl-adenylate without the requirement for a thiol ester intermediate. Adenylation reactions, such as those catalyzed by this superfamily, require Mg2+ and ATP to complex with the phosphoester oxygens and enhance the electrophilicity of the phosphorus atoms. As expected, we found PBS3 activity requires Mg2+ and ATP. We also found alkaline pH is necessary for amino acid conjugation, but not the adenylation reaction, probably to deprotonate the attacking nucleophile, the alpha-NH+3 group of the amino acid substrate (pKa approximately9.5). This is consistent with the pH requirements of other characterized GH3 enzymes (12) but is not a hallmark of all superfamily members. The reactions catalyzed by other superfamily family members, such as CoA ligases, do not use an amino acid as the nucleophile, and thus an alkaline pH would not be required as it is for PBS3.
###end p 63
###begin p 64
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 604 610 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3-1</italic>
We are limited in our analysis of PBS3 by the lack of a crystal structure for a GH3 enzyme and by the limited sequence conservation with other acyl-adenylate/thioester-forming superfamily members. However, the AMP-binding motifs of PBS3 are evident, and the importance of these motifs has been clearly demonstrated for GH3 enzymes. For example, in JAR1, mutation of a conserved residue of AMP-binding motif I results in a complete loss of activity (7). To date, no other known motifs have been identified in PBS3 or other GH3 enzymes. However, our study of the impact of the point mutations contained in pbs3-1 on PBS3 activity, with loss of adenylation activity for both E502K and I519T PBS3 mutants, suggests that the highly conserved C-terminal region of PBS3, including loop residue Ile-519 (see supplemental Fig. S2), may participate in substrate binding or catalysis.
###end p 64
###begin p 65
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">meta-</italic>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ortho-</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ortho</italic>
###xml 412 416 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Meta</italic>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
In terms of acyl substrate specificity, PBS3 had the highest velocity with 4-HBA and pABA (4-ABA) of the compounds tested (Table 2). However, bulkier groups at the para-position, such as 4-AMeBA or 4-AEtBA, were not well tolerated. Substitution at the meta- and ortho-positions led to substantially lower reaction velocity with ortho substitutions resulting in lack of activity, perhaps due to steric hindrance. Meta substitutions were tolerated and more electronegative substituents such as MeO provided a 4-fold enhancement of activity compared with -OH substitutions. In addition, our results comparing PBS3 activity with benzoate versus phenylacetate suggest that it is important for the carboxylate group to be attached directly to the aromatic ring, likely for resonance stabilization. The fact that PBS3 exhibited moderate activity with trans-cinnamate, which has a double bond between the carboxylic acid and aromatic ring, supports this conclusion. However, another explanation for the lack of activity with phenylacetate is that although the cinnamates and benzoates display a planar geometry, phenylacetate does not, and thus may be perceived quite differently by the active site.
###end p 65
###begin p 66
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 601 612 601 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 675 683 675 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1099 1100 1098 1099 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1224 1228 1223 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
The observed substrate preference of PBS3 for subsets of benzoates is similar to that observed for glycosyltransferases and CoA ligases active on benzoate substrates (31). Despite the clear preference for benzoates, PBS3 was also moderately active on trans-cinnamate (Table 2). This is unusual, as glycosyltransferases and CoA ligases active on benzoates have not been reported to have significant activity on cinnamates (32, 33). Similar to PBS3, the few characterized GH3 proteins have exhibited clear substrate preferences while remaining active on a fairly broad range of substrates. For example, Arabidopsis Group II GH3 proteins are capable not only of adenylating IAA in vitro but also adenylating other compounds with auxin activity, including indole-3-pyruvate, indole-3-butyrate, and the structurally distinct phenylacetate and naphthalene acetate (12). We also observed that SA inhibits both the adenylation and full (adenylation and amino acid conjugation) PBS3 reactions. Furthermore, the restoration of maximal PBS3 velocity when excess pABA is added to the reaction mixture with 15 mum SA suggests SA acts as a competitive inhibitor of PBS3. In this capacity, SA most likely competes with the acyl substrate (e.g. pABA) for the active site in a mutually exclusive fashion. Although less frequently observed, it is also possible that SA could act as an allosteric competitive inhibitor, binding a distinct site on PBS3.
###end p 66
###begin p 67
###xml 370 371 370 371 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 562 570 562 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 786 797 786 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 886 894 886 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1164 1170 1164 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1309 1316 1297 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table 3</xref>
###xml 1475 1484 1463 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
Although PBS3 tolerates a range of benzoates as substrates, there is a strict requirement for Glu as the amino acid substrate with pABA. No activity was observed with the other 19 amino acids, including Asp which differs from Glu by only one methylene group. In addition, modified forms of Glu were inactive. This suggests a precise configuration of the active site for l-glutamic acid. The strict requirement for Glu is unusual among the few characterized GH3 enzymes, which are capable of conjugating the addition of multiple amino acids to the acyl substrate in vitro. For example, JAR1 catalyzes the addition of jasmonate to at least 11 amino acids and the ethylene precursor 1-amino-cyclopropane-1-carboxylate (7). JAR1 does not, however, appear to form Glu or Asp conjugates. The Arabidopsis Group II GH3 proteins also catalyze the formation of multiple IAA-amino acid conjugates in vitro, including those with Glu and Asp (12). Some of these IAA-conjugating proteins, such as GH3.17, exhibit a strong preference for either Glu or Asp (12). Surprisingly, with 4-HBA as the acyl substrate, PBS3 can utilize a number of amino acids, including Glu but not Asp (Fig. 2). What accounts for this difference in amino acid specificity? PBS3 exhibits approximately3-fold higher affinity for pABA than for 4-HBA (Table 3). Perhaps the pABA-AMP intermediate more precisely fits the active site, constraining acceptable amino acids for use in the conjugation reaction. In terms of in planta activity, this would depend upon the relative availability of acyl and amino acid substrates.
###end p 67
###begin p 68
###xml 0 68 0 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kinetic Parameters of PBS3 and Physiological Relevance of Substrates</italic>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 123 125 123 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 134 135 133 134 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 165 166 163 164 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 182 183 179 180 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 186 193 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table 3</xref>
###xml 201 202 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 200 202 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 306 308 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 329 330 325 326 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 374 375 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 375 378 371 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 409 411 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 447 448 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 448 451 444 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cat</sub>
###xml 674 683 670 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 824 825 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 823 825 819 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
Kinetic Parameters of PBS3 and Physiological Relevance of Substrates-We found that PBS3 had the highest affinity for pABA (Km = 153 mum), compared with 4-HBA (459 mum) and BA (867 mum) (Table 3). One Km value that has been reported previously for a GH3 family member is that of JAR1 for (-)-jasmonic acid (34). This value, 190 mum, is similar to what we found for PBS3. The kcat for PBS3 with 4-HBA (20.36 min-1) was 7- and 5-fold higher than the kcat with pABA or BA, respectively. This resulted in similar catalytic efficiencies for 4-HBA and pABA, compared with that of BA, which was much lower. Taken together, these findings suggest 4-HBA and pABA as likely substrates in planta. However, to assess the relevance of our findings, we must consider the physiological concentrations of the substrates of PBS3. How do the Km values we have determined compare with physiological concentrations of these substrates?
###end p 68
###begin p 69
###xml 3 14 3 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 213 224 201 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 233 235 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 452 463 440 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 546 557 534 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 649 650 637 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 648 650 636 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 674 675 661 662 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 677 679 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 691 692 677 678 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 694 696 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 719 720 704 705 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 722 724 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 753 754 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 752 754 737 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 768 779 753 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 842 843 826 827 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 845 847 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1039 1040 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1038 1040 1022 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1049 1050 1032 1033 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1154 1163 1137 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 213 224 <span type="species:ncbi:317">P. syringae</span>
In Arabidopsis, pathogen-induced BA levels have been rarely reported, although BA levels of approximately4 nmol/g FW, assessed using gas chromatography-MS, were detected at 2 days post-inoculation with a virulent P. syringae strain (35). As pathogen-induced BA levels have not been measured with sufficient temporal (or spatial) resolution to be confident in physiological concentrations, we also reviewed reports of the affinity of pathogen-inducible Arabidopsis enzymes for BA to provide insight into relevant physiological concentrations. The Arabidopsis glucosyltransferases with the highest activity and affinity for BA have reported apparent Km values for BA of 260 mum (31) and 540 mum (32) for UGT74F1 and 80 mum (31) for UGT74F2. The apparent Km value of the Arabidopsis SA/BA methyltransferase AtBSMT1 for BA is reported to be 65 mum (36). These affinities suggest that physiological concentrations of BA are insufficient to support efficient catalysis by PBS3 using BA as the acyl substrate. Therefore, given the low affinity (Km = 867 mum) and catalytic efficiency of PBS3 with BA, it appears that BA may not be the favored substrate of PBS3 in planta.
###end p 69
###begin p 70
###xml 30 41 30 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 546 553 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 681 692 681 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 840 841 840 841 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 839 841 839 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 911 912 910 911 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 914 916 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1168 1170 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 1307 1329 1306 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ralstonia solanacearum</italic>
###xml 1342 1344 1341 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 1429 1438 1428 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 1307 1329 <span type="species:ncbi:305">Ralstonia solanacearum</span>
###xml 1333 1340 <span type="species:ncbi:4097">tobacco</span>
pABA-Glu has been detected in Arabidopsis leaves at 0.3 nmol/g FW and is thought to be present as a breakdown product of folates (37). Folates consist of three subunits as follows: a pterin moiety, pABA, and varying numbers of glutamic acids. They are essential cofactors in one-carbon transfer reactions, which are central to plant metabolism, and are involved in the synthesis of methionine, pantothenate, purines, pyrimidines, and thymidylate (38). It may be that pABA-Glu is not just a breakdown product of folate but is actually synthesized de novo in response to biotic stress. Although an increase in pABA or pABA-Glu has not been detected in response to pathogen attack in Arabidopsis, pABA-Glu is not likely to be efficiently isolated using standard procedures for the measurement of metabolites like SA (3, 39, 40). The apparent Km value of the pABA-glucosyltransferase for pABA was found to be 120 mum (41), which is quite similar to the value we found for PBS3. Perhaps the formation of pABA-Glu conjugates is a way for plants to restrict access of the pathogen to free pABA. Bacteria can commonly import pABA but few have been found that import pABA-Glu (42). Furthermore, there is precedent for pABA limitations on the growth of phytopathogens, as observed for growth of a folate auxotroph of Ralstonia solanacearum on tobacco (43). Therefore, pABA remains an attractive candidate as a potential substrate for PBS3 in planta.
###end p 70
###begin p 71
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 574 585 574 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 624 635 624 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 674 685 674 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tomato</italic>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 989 1000 977 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 1044 1045 1032 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1043 1045 1031 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1066 1067 1053 1054 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1079 1081 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1087 1113 1074 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lithospermum erythrorhizon</italic>
###xml 1207 1208 1194 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1206 1208 1193 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1254 1255 1240 1241 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1257 1259 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 1261 1263 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1323 1332 1309 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 595 601 <span type="species:ncbi:4039">carrot</span>
###xml 674 696 <span type="species:ncbi:323">P. syringae pv. tomato</span>
###xml 1087 1113 <span type="species:ncbi:34254">Lithospermum erythrorhizon</span>
4-HBA is typically known as an intermediate in the synthesis of ubiquinone, a lipid-soluble electron carrier of the mitochondrial electron transport chain (44). Therefore, all plants normally produce 4-HBA in small quantities. However, some plants use 4-HBA in the synthesis of specialized metabolites such as shikonin (45), and 4-HBA is often found associated with the plant cell wall, typically as a component of lignin (46). Pathogen (or elicitor-)-induced synthesis of 4-HBA and incorporation into the plant cell wall has been reported for a number of plants, including Arabidopsis (47) and carrot (48). For example, in Arabidopsis in response to virulent and avirulent P. syringae pv. tomato DC3000, 4-HBA accumulated to 0.2 nmol/mg cell wall by 72 hours post-infection (47) or approximately5 nmol/g FW (calculated using our milligrams of cell wall/g FW conversion factor obtained with this cell wall preparation protocol). Enzymes that use 4-HBA as a substrate include five putative Arabidopsis 4-HBA glucosyltransferases, which exhibit Km values of 210-290 mum for 4-HBA (31) and Lithospermum erythrorhizon geranyldiphosphate, 4-HBA geranyltransferases involved in shikonin synthesis, with reported Km values for 4-HBA ranging from 18.4 to 45.9 mum (45, 49). Therefore, 4-HBA remains an attractive candidate for the in planta substrate for PBS3, with 4-HBA/4-HBA-Glu perhaps playing a role in pathogen-induced cell wall remodeling.
###end p 71
###begin p 72
###xml 117 125 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 270 279 270 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 329 337 329 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 528 539 528 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 564 568 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">jar1</italic>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 798 807 798 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in planta</italic>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 999 1010 999 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 1127 1138 1127 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
As the analytical methods required to extract, enrich, and detect these putative conjugates are highly specific, our in vitro analysis now allows us to employ methods specific to these compounds and to the analysis of compounds incorporated into the cell wall. To date, in planta activities of GH3 enzymes appear consistent with in vitro findings. For example, IAA-Asp is one of the dominant IAA-amino acid conjugates formed by GH3.6 as evaluated by TLC, and overexpression of GH3.6 results in a 4.5-fold increase in IAA-Asp in Arabidopsis leaves (12). Similarly, jar1 mutants exhibit >7-fold reduction in JA-Ile levels, and JA-Ile is a dominant JA-amino acid conjugate observed by TLC (7). Consistent with the preference of PBS3 for Glu, the only endogenous benzoyl-amino acid conjugates detected in planta have been either Glu or Asp conjugates (e.g. pABA-Glu (37), 4-HBA-Glu (50), SA-Asp (51), and BA-Asp (28)). As PBS3 is not active with Asp, it will be interesting to determine whether another Arabidopsis GH3 family member exhibits overlapping acyl substrate specificity but altered AA preference, as is the case for the Arabidopsis GH3 family members acting on IAA (12). This possibility may also require the use of a PBS3 overexpresser to detect significantly altered levels of putative Glu conjugates.
###end p 72
###begin p 73
###xml 0 77 0 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">How Does PBS3 Function Impact SA Metabolism and SA-dependent Gene Expression?</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3</italic>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gdg1</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">win3</italic>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref53">53</xref>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gh3.12</italic>
###xml 470 473 470 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PR1</italic>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">1</xref>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">2</xref>
###xml 1229 1231 1229 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1239 1240 1238 1239 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1361 1362 1360 1361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1360 1362 1359 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1370 1371 1368 1369 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1381 1383 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1404 1405 1402 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1403 1405 1401 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1436 1447 1434 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 1540 1541 1537 1538 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1550 1552 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1554 1556 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1630 1637 1627 1634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 1689 1700 1686 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 1789 1790 1785 1786 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1854 1855 1849 1850 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1867 1869 1862 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 1705 1712 <span type="species:ncbi:4097">tobacco</span>
###xml 1714 1734 <span type="species:ncbi:12242">tobacco mosaic virus</span>
How Does PBS3 Function Impact SA Metabolism and SA-dependent Gene Expression?-Previous analyses of pbs3/gdg1/win3 mutants by us and others showed that the lack of function of AtGH3.12 (PBS3) reduced total (free and glucose-conjugated SA (SAG)) pathogen-induced SA accumulation, activation of SA-dependent gene expression, and disease resistance (3, 52, 53). Furthermore, exogenous application of SA to gh3.12 mutants induced the expression of SA-dependent genes such as PR1 and rescued the enhanced disease susceptibility phenotype (3, 52). Therefore, the most likely position for PBS3 function would be upstream of SA biosynthesis. The action of PBS3 upstream of SA rather than on SA itself is further supported by the observed substrate specificity of PBS3, with PBS3 being inactive on SA (Tables 1 and 2). It is not likely that PBS3 functions through modulation of the activity of SA biosynthetic enzymes, as we found the activity of AtICS1 and a surrogate IPL were not affected by favored PBS3 substrates or products. Furthermore, if PBS3 acted in this way to promote SA biosynthesis and subsequent formation of the SAG conjugate, it would not make sense for PBS3 activity to then be inhibited by low concentrations of SA (IC50 = 15 mum SA). Of interest, AtBSMT1, which catalyzes the formation of MeSA from SA, functions at these low concentrations of SA (Km = 16 mum for SA) (36). In contrast, the Km value of the pathogen-induced Arabidopsis SA glucosyltransferase 1 (UGT 74F1; At2g43840), which converts free SA to SAG, is 190-230 mum for SA (31, 32), suggesting higher concentrations of SA are required for SAG formation. In situ quantification of free SA has not been reported in Arabidopsis. In tobacco, tobacco mosaic virus inoculation resulted in free SA accumulation of 6.5 mum at 16 hpi with maximal detected local concentrations of >200 mum at 40 hpi (54).
###end p 73
###begin p 74
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 745 756 745 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 801 812 801 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 817 827 817 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maculicola</italic>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
###xml 930 934 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3</italic>
###xml 1043 1047 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ics1</italic>
###xml 1048 1052 1048 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sid2</italic>
###xml 1055 1059 1055 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">eds5</italic>
###xml 1065 1069 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">npr1</italic>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
###xml 1245 1256 1245 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. syringae</italic>
###xml 1261 1271 1261 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maculicola</italic>
###xml 1289 1293 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ics1</italic>
###xml 1322 1326 1322 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pbs3</italic>
###xml 1335 1337 1335 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
###xml 1575 1577 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref56">56</xref>
###xml 2351 2359 2351 2359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2605 2606 2605 2606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 2700 2704 2700 2704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 801 827 <span type="species:ncbi:59511">P. syringae pv. maculicola</span>
###xml 1245 1271 <span type="species:ncbi:59511">P. syringae pv. maculicola</span>
###xml 1374 1380 <span type="species:ncbi:4039">carrot</span>
Therefore, it is likely that PBS3 functions upstream of SA, early in the defense response when SA levels are low. In this scenario, PBS3 activity leads to conjugate formation (e.g. 4HBA-Glu), which signals or primes SA biosynthesis. PBS3 activity is then no longer required once SA synthesis has been sufficiently initiated. The inhibition of PBS3 by SA serves as a mechanism to rapidly reduce synthesis of the conjugate when it is no longer necessary for SA priming. In this scenario, we would expect a reduced conjugate (e.g. 4-HBA-Glu) concentration as the defense response progresses. A role for PBS3 upstream of SA in a regulatory capacity is also supported by recent expression profiling comparing expression of wild type and a variety of Arabidopsis mutants in defense signaling at 24 hpi with P. syringae pv. maculicola ES4326 using a custom mini array (55). In this study, PBS3 was placed upstream of SA and NPR1, as the pbs3 mutation impacted the expression of many more genes than the standard SA biosynthesis and signaling mutants ics1(sid2), eds5, and npr1 (55). Of interest, the expression of chalcone synthase, a key enzyme directing flux to flavonoid biosynthesis from 4-coumaroyl-CoA, was strongly down-regulated at 24 hpi with P. syringae pv. maculicola in wild type and ics1 but was up-regulated in the pbs3 mutant (55). In other systems such as elicited carrot cell cultures, up-regulation of 4-HBA synthesis and enhanced flux through the general phenylpropanoid pathway was associated with down-regulation of flavonoid biosynthesis from 4-coumaroyl-CoA (56). This suggests that flux from 4-coumaroyl-CoA to phenylpropanoid cell wall precursors may be up-regulated to facilitate the observed cell wall remodeling. Therefore, it is possible that PBS3 coordinately modulates pathogen-induced SA, 4-HBA, and their associated responses with 4-HBA playing a role in cell wall remodeling and the direction of chorismate flux (from 4-coumaroyl-CoA) for this purpose. Future work will address this possibility and potential mechanisms of action. For example, given the known function of phytohormone-AA conjugates in promoting or inhibiting the ubiquitin ligase-dependent proteasomic degradation of the associated transcriptional repressor, it is tempting to speculate that 4-HBA-Glu may act in a similar manner. With our knowledge of the in vitro specificity of PBS3 gained through this study, potential PBS3 products could be used in assays with candidate F-box proteins and repressors to identify F-box-repressor interactions mediating SA and/or 4-HBA-associated signaling (similar to Ref. 8 for JA). This is critical as these interactions require binding of the appropriate molecule, e.g. JA-Ile for JA signaling.
###end p 74
###begin p 75
###xml 248 256 248 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1085 1093 1085 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1675 1677 1675 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref57">57</xref>
###xml 1679 1681 1679 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref58">58</xref>
###xml 1871 1873 1871 1873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref59">59</xref>
In summary, this study further supports the critical role of amino acid conjugation of small molecules in phytohormone regulation and homeostasis. To date, this conjugation is catalyzed by members of the GH3 enzyme family. Here we characterize the in vitro activity of the first GH3 subfamily III member to be analyzed, PBS3 (AtGH3.12). In the process, we developed a high throughput adenylation assay to screen for preferred acyl substrates of GH3 enzymes. This high throughput assay can be applied to the identification of substrates for other GH3 enzymes for which no acyl substrates have been identified or inferred through analysis of mutant phenotypes. We also determine kinetic parameters for recombinant PBS3 and demonstrate that PBS3 is specifically inhibited by low concentrations of SA. This is important as it presents a novel mechanism for rapidly and reversibly fine-tuning the activity of small molecules, including phytohormones. It could also be a mechanism for rapid and reversible cross-talk between phytohormones or other small molecules, such as SA and 4-HBA. Our in vitro analyses of PBS3 suggest a potential, underexplored role for 4-HBA (and/or pABA) and their respective amino acid conjugates in plantmicrobe interactions and provide a framework to explore the mechanism by which PBS3 impacts pathogen-induced SA accumulation and disease resistance. In addition, using knowledge of the substrate preferences and biochemical and kinetic properties of PBS3, one could test and optimize PBS3 for use in biotechnological applications. For example, PBS3 might be used to remove and purify 4-HBA, an inhibitory by-product of cellulosic ethanol production (57, 58). 4-HBA, hydrolyzed from the 4-HBA-AA conjugate, could then be sold to the liquid crystal polymer industry, as it is a preferred monomer used in the manufacture of liquid crystal polymers (59).
###end p 75
###begin p 76
###xml 144 157 <span type="species:ncbi:444978|species:ncbi:287">P. aeruginosa</span>
We thank Marcus Strawn (Wildermuth laboratory) for purified isochorismate, recombinant Arabidopsis isochorismate synthase (AtICS1), recombinant P. aeruginosa isochorismate pyruvate lyase (PchB), and valuable discussions regarding this research. We thank Eric Simmons and Dr. Richmond Sarpong (University of California, Berkeley) for their generous assistance with synthesis of 4-HBA-Glu. We thank Dr. Allis Chien and Theresa McLaughlin of the Vincent Coates Foundation Mass Spectrometry Laboratory (Stanford University) for mass spectrometry analyses, Dr. Chloe Zubieta for creating the single PBS3 mutant constructs, and Dr. Krishna Niyogi (University of California, Berkeley) for use of the Spectramax Plus microplate spectrophotometer (Molecular Devices). We also thank M. Strawn and Drs. K. Niyogi and D. Burgess for their comments on the manuscript.
###end p 76
###begin p 77
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">para</italic>
The abbreviations used are: PBS3, avrPphB susceptible 3 (GH3.12); AA, amino acid; BA, benzoate; 4-HBA, 4-hydroxybenzoate; FW, fresh weight; IAA, indole-3-acetate; JA, jasmonate; pABA, para-aminobenzoate; SA, salicylate; MeSA, methyl salicylate; SAG, SA glucoside; ICS1, isochorismate synthase 1; IPL, isochorismate pyruvate lyase; Q-TOF, quadrupole time of flight; MS/MS, tandem mass spectrometry; DTT, dithiothreitol; HPLC, high pressure liquid chromatography; 4-AEtBA, 4-aminoethylbenzoate; LC, liquid chromatography; INA, 2,6-dichloroisonicotinate.
###end p 77
###begin p 78
M. Estelle, personal communication.
###end p 78

